FAQ.2012第21周更新

合集下载

网络电话的语音质量评估：泰国用户基于访谈测试的G.711与 G.722(IJITCS-V4-N2-3)

Abstract—This paper presents the comparison between two codecs, G.711 and G.722 at 64 kbps, referring to speech quality perception using a subjective method called interview tests. These subjective tests have been conducted with 201 subjects, who are Thai native speakers that use Thai which is a tonal language, for accuracy and reliability of results. The results from testing with both codecs are almost the same; the scores are 4.17 for G.722 and 4.14 for G.711. After analyzing the results, it has been confirmed that G.722 does not provide better speech quality than G.711 to the Thai subjects significantly, which is consistent with previous information. However, these results could be used as the benchmark of G.711 and G.722 for speech quality assessment within Thai environments. Index Terms—VoIP, speech quality assessment, speech quality evaluation, speech quality measurement, subjective methods, subjective methods tests, G.711, G.722, Thai

F106-趋势科技-NVWE_FAQ_All0622

Network VirusWall 1200 FAQ第一、一般营销问题问题：如今客户所面临的最大安全问题是什么?答: 各种组织都面临下面三项挑战：1、网络病毒（互联网蠕虫），比如正在困扰全球组织的Blaster 和Slammer。

根据Computer Economics的估算，仅这两种病毒在2003年造成的损失就高达21.5亿美元。

2、从发现漏洞到病毒发作之间的时间越来越短。

例如，从发现Nimdas 所利用的漏洞到Nimda 出现之间的时间为一年。

而Blaster 仅不到一个月。

3、来自网络中旧病毒循环传播的反复感染依然令人头疼，而未经保护的设备通过多个进入点接入网络的情况使这一问题继续恶化。

2003年排名前十位的病毒中有一半早在1-4年前就已出现。

问题：什么是网络病毒?答：1、当数据沿网络从一台计算机传往另一台计算机时，它就像拼图一样被分解为小的信息包或片断，然后在到达目的地后重组为一个完整文件。

诸如Blaster 或Slammer 等网络病毒可以隐藏在这些信息包中，从而不受监视地进入目标系统，并可在全部信息包重组为传统防病毒解决方案可以扫描的完整文件之前就开始制造混乱。

2、网络病毒使用诸如TCP/UDP 等网络端口，并能够利用安全漏洞来复制传播和进行感染。

3、与Sobig 或MyDoom 等群发邮件型的病毒不同，网络病毒并不需要用户点击电子邮件附件。

问题：为什么趋势科技将网络病毒视为最大的安全问题?答：1、自2001年起，尽管各种组织都投资了各式各样的安全技术，但是网络病毒问题目前仍未得到解决。

2、对于某些组织而言，他们需要三个月的时间来清除Blaster 病毒，因为他们缺乏能够监视这些攻击、封堵病毒传播的路径以及消除和清除感染的综合解决方案。

3、随着软件漏洞数量的增多，网络病毒攻击携带恶性有效负荷的可能性就越大。

问题：Network VirusWall 如何来解决这个最大的安全问题?答：Network VirusWall 可以通过下列功能来解决这个问题：1、在发作期间封堵高威胁性的漏洞（未安装补丁的计算机)。

M-Patch 2.1 用户手册 2012年9月说明书

M-Patch 2.1ManualSeptember 2012SAFETY INSTRUCTIONSCAUTION: To reduce the risk of electrical shock, do not remove the cover or rear panel of this unit. No user serviceable parts inside. Please refer servicing to qualified personnel only.WARNING: To reduce the risk of fire or electrical shock do not expose this appliance to rain or moisture.DETAILED SAFETY INSTRUCTIONS:All safety and operation instructions of this manual should be read and adhered to before operation.Retain Instructions:Please retain all safety and operating instructions for future reference.Follow instructions:All operation and user instructions should be followed.Water, liquid and Moisture:The appliance should not be used near water, rain or other liquids. Make sure that no liquid can leak, spill or otherwise seep into the appliance.Ventilation:Please place the appliance so no obstacles interfere or impede the flow of air through the ventilation openings.Heat:The appliance should be situated away from other heat sources such as heaters, radiators, ovens, or other appliances that produce heat.Power Source:Make sure your appliance is set to the correct voltage for the country in which it will be use before switching the device ON.Grounding and Polarization:Precautions should be taken so that the grounding or polarization means of an ap-pliance is not defeated.Power-Cord Protection:Power supply cords should be routed so that they are not likely to be walked on, pinched, damaged, worn, or rubbed by any other device or obstacle.Cleaning:The appliance should be cleaned only with a light soft cloth. Do not use any dama-ging or corrosive products on the unit.Periods of inactivity:The power cord of the appliance should be unplugged from the outlet when left un-used for a long period of time or in case a lightning storm occurs.Damage Requiring Service:The appliance should be serviced by qualified service personnel when:• The power supply cord or the plug has been damaged; or• Objects have fallen, or liquid has been spilled into the appliance; or• The appliance has been exposed to rain; or• The appliance does not appear to operate normally or exhibits a marked change in performance; or• The appliance has been dropped, or the enclosure damaged.Servicing:The user should not attempt to service the appliance beyond that is described in the Operating Instructions.All other servicing should be referred to qualified service personnel.FOREWORDDear Customer, Thank you very much for expressing your confidence in SM Pro Audio products by purchasing this unit. The M-Patch 2.1 was designed to be a com-prehensive “workhorse” test device for home, project and professional studios, live sound rental companies, repair centers, schools and fixed installations- in short, virtually any and all venues where audio products are used. Drawing on years of hands-on experience in the audio industry and valuable suggestions from our cus-tomers, our engineers have developed a product that we are certain will more then meet your expectations. As with all SM Pro Audio equipment, the M-Patch 2.1 was designed to provide you with a superb performance, excellent technical specifica-tions and uncompromised audio quality at an extremely affordable price.Regards, SM ProAudioIt should be pointed out, that extreme output volumes may damageyour ears and/or your headphone units. Turn down the LEVELcontrols before you switch on the unit.PLACEMENTThe SM Pro Audio M-Patch 2.1 utilizes an electronic circuit. Be sure that there is enough air space around the unit for cooling. To avoid overheating, please do not place the units on high temperature devices such as power amplifiers or near other units which may have high frequency transmittance such as wireless devices.Mains voltageThe unit comes with a 12V - 16V DC power supply adaptor. Before you connect your unit to the mains, please make sure that your local voltage matches the voltage required by the unit! Any damage occurring as a result of an incorrect power supply selection may not be granted a warranty repair.SM M-Patch 2.1 Main FeaturesProfessional, multi-purpose passive volume attenuator with built in headphone amplifier.Dual L/R Balanced Combination XLR–1/4” TRS Inputs Dual L/R Unbalanced RCA In-puts Dual 1/8” (3.5mm) TRS Stereo Inputs Dual Balanced XLR Master Outputs Dual Balanced XLR L/R Outputs Balanced XLR Subwoofer Output with Optional Variable Crossover L/R Balanced Sub/Crossover Returns Three Independent Rotary Analog Stereo Volume Controls 1/4” TRS Stereo Headphone Output Headphone Volume Control 1/4” TS Remote Mute Input Five Output Selector Switches with Mutes Ste-reo/Mono Summing Switch Master Mute Switch1. INTRODUCTIONIn purchasing the new M-Patch 2.1, you have acquired a passive volume control device of high class that meets the demands of the most professional studios.An affordable high-quality problem solver for mixer-less DAW and nonlinear video production environments, the M-Patch 2.1 provides an ideal desktop or rack mount stereo level control solution for any monitoring or distributed sound application.The M-Patch 2.1 is a multi-channel stereo attenuator using passive circuitry designed for users wishing to work without outboard mixers or bit-degrading digital volume at-tenuators. The M-Patch 2.1 provides stereo level control solutions for any monitor or distributed sound application. Featuring two rotary controls for precise two x stereo channel level adjustments, and housed in a desktop or rack-mountable sized chas-sis, the M-Patch 2.1 main volume controller is designed from discrete 0.5% resistors with a switched mechanism which is far more accurate then the standard variable resistors which are used in other products especially at lower volumes. It features the ability to return the signal from the subwoofer back into the M-Patch 2.1 and control it, along with the left/right monitors, from the master volume attenuator. Plus A dedicated mute switches make it easy to A/B mixes with or without the subwoofer.2. THE DESIGN CONCEPT2.1 High quality components and designThe philosophy behind SM ProAudio products guarantees a no-compromise circuit design and employs the best choice of components.2.2 Inputs and outputsAll inputs and outputs are secured firmly to the exterior chassis housing. This en-sures robust quality and confidence in performance under all conditions.3. InstallationYour SM Pro Audio M-Patch 2.1 was carefully packed in the factory and the packag-ing was designed to protect the unit from rough handling. Nevertheless, we recom-mend that you carefully examine the packaging and its contents for any signs of physical damage, which may have occurred in transit.If the unit is damaged, please do not return it to us, but notify your dealer and the shipping company immediately, otherwise claims for damage or replacement may not be granted. Shipping claims must be made by the consignee.3.1 Desktop or Rack-mount installationThe SM Pro Audio M-Patch 2.1 can sit comfortably on your desktop. We also include a versatile pair of rack mounting ears.3.2 Audio input ConnectionsThe M-Patch 2.1 features four (4) separate input channels named “Aux” & “Balan-aced”. The connections are found on the rear panel. (Input section on rear panel of M-Patch 2.1).* Note: The M-Patch 2.1 accepts mic or line level input signals. Do notconnect your power amplifier outputs to the M-Patch 2 inputs!3.2.1 Balanced inputsThe balanced main inputs feature XLR bal/unbalanced combo connectors for L&R input signal. This input is perfect for connection to your main audio interface devices. Simply connect your cables directly to the unit with either XLR or ¼” TS/TRS cables. You are then able to select between these 2 Balanced inputs and attenuate their input signal.3.2.2 Aux inputsThe Aux input channels features two different connection possibilities in the form of 2 x RCA (L&R) and a stereo 3.5mm mini-jack input. These connections are perfect for devices such as a CD players line output or a 3.5mm stereo mini-jack connection from your PC‘s standard soundcard.* Note: You can connect up to six different devices to the three physical connector possibilities simultaneously. The input selector on the front panel allows selection of the desired input!3.3 Analog audio outputsThe M-Patch 2.1 features three (3) pairs (L&R) of XLR balanced analog output con-nectors on the rear panel plus a subwoofer balanced XLR output.Connect these outputs to your destination device (active monitors, digital recorder, or wherever you need the attenuated output signal sent).* Note: It is possible to activate or deactivate each desired output pair via the output selector switches‘ on the front panel. It is possible to have both master 1 & master 2 outputs active at the same time. This is very useful when connecting the outputs to a recording device and a monitoring device simultaneously!The Subwoofer direct output can be used to connect to an active subwoofer speaker or via a power amp to a passive subwoofer, NO cross over is installed inside the M-Patch 2.1 (we will be releasing cross over modules at a later time which can fitted to the M-Patch 2.1).One of the unique features of the M-Patch 2.1 is the ability to use Active Subs which have cross overs built in them for the full range satellite speakers. In this situation, you would connect the MASTER 1 output to the Active subwoofer;s inputs and then the outputs of these to the XOVER/SUB Return input on the M-Patch 2.1, then use the LR Send/2.0 output to connect to your satellite speakers.* NOTE: Do not connect amplified inputs to the M-Patch 2.1!4. FRONT PANEL CONTROLS4.1 Master SectionThe master section lets you select between the BALANCED or AUX inputs, select MONO or STEREO listening mode for your monitors as well as MUTE all the outputs. The main attenuator is made from precision 12 step switch which has 6 separate pre-cision resistor networks to enable accurate attenuation of Left/Right and Subwoofer controls simultaneously in a passive manner.4.2 Headphone amplifierA headphone amplifier is provided for monitoring the audio signal selected by the ‚Input Selection‘ control switches.Simply connect a pair of headphones to the ¼” TRS headphone connector socket and use the rotary headphone volume control knob to adjust the volume level to your desired setting.* Note: Use of the headphone amplifier requires the connection of the external power supply.4.3 Output selector switches2.0LR/2.1 selector: When the M-Patch 2.1 is used as per the 2.1 setup below, this switch (IN 2.0LR position) enables you to route the audio signal directly to the L/R satellite speakers without going thru the subwoofer and it’s cross over, basically giv-ing you full range output.In the 2.1 position the audio signal will first flow to the subwoofer then back intothe M-Patch2.1 (XOVER/SUB RETURN) and out to the Satellite speakers. This ef-fectively gives you a way of switching between a 2.0 and 2.1 speaker configurations.Master 1 MUTE: A Mute switch for MASTER 1 outputMaster 2 MUTE: A Mute switch for MASTER 2 outputLR SEND MUTE: A Mute switch for LR SEND / 2.0 outputSUB MUTE: A Mute switch for the SUBWOODER output5. APPLICATIONUsing the M-Patch 2.1You can use M-Patch 2.1 anywhere you want to trim the amount of gain; ie, reduce the volume of analog audio signals. For example, you could use one to trim the output of a microphone pre-amplifier. With its high-quality potentiometers and mas-ter attenuator switch, the M-Patch 2.1 passes signal more accurately, and sounds better than most built-in volume controls. Another use might be to trim the levels of a 5.1 or greater multi-channel monitor system - either one pair of channels, or two, or all of them. You can also use the M-Patch 2.1 to trim the output level of a Digital to Analog Converter like those found in high end pre-amplifiers. It is also useful as a local volume control for distributed audio systems. The possibilities are endless! Handy applications... The M-Patch 2.1 is great for those times when you prefer to monitor directly from the outs on your sound card or audio interfaces main outputs directly to your monitors. When your monitors are on they are normally extremely loud. As a result, you may become a bit frustrated as the volume is often simply too high to be comfortable. Your only choice is to hook up through an external mixer and attenuate the signal or to attenuate the signal in the computer outputs, thereby degrading your bit-levels. Neither solution is completely satisfying. Mixers add color to the signal and reducing the digital output in the computer will compromise the fidelity of your audio.Simple steps for your home workstation… Typically you should connect the output of your soundcard or audio interface to the input of the M-Patch 2.1 using RCA, TRS or XLR jacks. You could also connect multiple connections at the same time if required. For example, connect the outputs of your audio interface to the balanced combo con-nectors, and your soundcards mini-jack output to the stereo 3.5mm AUX input on the M-Patch 2.1 You could also connect your CD or other line level device to the AUX RCA inputs. This enables you to level balance two input sources by passive attenuation! Connect XLR cabl es from the outputs of the M-Patch 2.1 to your active monitors or the amplifier that powers the monitors. Remember you have two (2) output destina-tions as well as a subwoofer output so if you have two different monitor pairs (near-field & far field (room speakers)) you can connect one pair to output 1 (L&R), and the other pair to output 2 (L&R) and share the same sub.Turn the volume all the way up on your monitors or amplifier, set your software & software volume control panel to Zero dB, and use the M-Patch 2.1 on your desktop to control your monitor level.Simple, effective, transparent!6. SPECIFICATIONSAUDIO INPUTSConnectors 4 x XLR Combo connectors2 x stereo RCA pair (L&R)2 x stereo 3.5mm jackAUDIO OUTPUTSOutput Connectors 3 x XLR output pairs1 x XLR mono subwoofer outputHEADPHONE OUTPUTOutput Connectors 1 x 14” TRS stereo outputFrequency response 20Hz20Hz +/- 0.5dBMaximum output level 320mW into 32ΩPOWERExternal DC12-16V adaptor*Note: Power is only required to operate the headphone amplifier and illuminate the units led indicators. All other functions of the M-Patch 2 will continue to function fully without the connection of the external power supply.PHYSICALDimensions (no rack ears) 37cm x 15.5cm x 8.5 cmNet weight approx. 2 kg7. W arranty7.1 Warranty CardTo be protected by this warranty, the buyer must complete and return the enc-losed warranty card (signed/stamped by retail dealer) within 14 days of the date of purchase to SM Pro Audio (see address below 3). Failure to return the card in due time (date as per postmark) will void any extended warranty claims.7.2 Warranty7.2.1. SM Pro Audio warrants the mechanical and electronic components of this product to be free of defects in material and workmanship for a period of one (3) years from the original date of purchase, in accordance with the warranty regulati-ons described below. If any defects occur within the specified warranty period that are not caused by normal wear or inappropriate use, SM Pro Audio shall, at its sole discretion, either repair or replace the product.7.2.2. If the warranty claim proves to be justified, the product will be returned freight prepaid by SM Pro Audio within Australia. Outside of Australia, the product will be returned at the buyer‘s expense.7.2.3. Warranty claims other than those indicated above are expressly excluded.7.3 Return Authorization Number7.3.1. To obtain warranty service, the buyer must call SM Pro Audio during normal business hours BEFORE returning the product (Tel.: +61 3 9555 8081). All inqui-ries must be accompanied by a description of the problem. SM Pro Audio will then ****************************************************************7.3.2. The product must be returned in its original shipping carton, together with the return authorization number, to the following address:SM Pro AudioService DepartmentW25, 26-28 Roberna StMoorabbinMelbourne, VictoriaAustralia 31897.4 Warranty Regulations7.4.1. Warranty services will be furnished only if the product is accompanied by an original retail dealer‘s invoice. Any product deemed eligible for repair or replace-ment by SM Pro Audio under the terms of this warranty will be repaired or replaced in the best possible manner.7.4.2. If the product needs to be modified or adapted in order to comply with applicable technical or safety standards on a national or local level, in any country which is not the country for which the product was originally developed and manu-factured, this modification/adaptation shall not be considered a defect in materials or workmanship.The warranty does not cover any such modification/adaptation, irrespective of whether it was carried out properly or not. Under the terms of this warranty, SM Pro Audio shall not be held responsible for any cost resulting from such a modification/ adaptation.7.4.3. Free inspections, maintenance/repair work and replacement of parts are expressly excluded from this warranty, in particular if caused by inappropriate use. Likewise, the warranty does not cover defects of expendable parts caused by normal wear of the product. Expendable parts are typically pots, potentiometers, switches and similar components.7.4.4. Damages/defects caused by the following conditions are not covered by this warranty:• Misuse, neglect or failure to operate the unit in compliance with the instruc-tions given in the user or service manuals.• Connection or operation of the unit in any way that does not comply with the tech-nical or safety regulations applicable in the country where the product is used.• Damages/defects that are caused by any other condition beyond the control of SM Pro Audio.7.4.5. Any repair carried out by unauthorized personnel will void the warranty.7.4.6. Products which do not meet the terms of this warranty will be repaired exclusively at the buyer‘s expense. SM Pro Audio will inform the buyer of any such circumstance. If the buyer fails to submit a written repair order within 4 weeks after notification, SM Pro Audio will return the unit C.O.D. with a separate invoice for freight and packing. Such cost will also be invoiced separately when the buyer has sent in a written repair order.7.5 Claim for DamagesFailure of SM Pro Audio to provide proper warranty service shall not entitle the buyer to claim (consequential) damages. In no event shall the liability of SM Pro Audio exceed the invoiced value of the product.7.6 Other Warranty RightsThis warranty does not exclude or limit the buyer‘s statutory rights provided by national law, in particular, any such rights against the seller that arise from a legally effective purchase contract.The information contained in this manual is subject to change without notice. No part of this manual may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying and recording of any kind, for any purpose, without the express written permission of SM Pro Audio.ALL RIGHTS RESERVED © 2012 SM Pro AudioAll illustrations, descriptions and technical specifications are subject tochange without prior notice.SM Pro Audio Service DepartmentW25, 26-28 Roberna St Moorabbin Melbourne, Victoria Australia 3189。

2200 evo Safety Release 3.0 chinese

禁止在电气 & 电子设备中使用某些危险物质
© 2012 Datacon Technology GmbH
2200 evo
17
版本 3.0
概要绪论
安全提示 — 第章 2
© 2012 Datacon Technology GmbH
版本 3.0
18
2200 evo
安全提示 — 第章 2
客户的职责概要
© 2012 Datacon Technology GmbH
2200 evo
13
版本 3.0
Certificates ISO 9001:2000 认证
2.
ISO 9001:2000 认证
ISO 9001:2000 认证示例：
安全提示 — 第章 1
© 2012 Datacon Technology GmbH
© 2012 Datacon Technology GmbH
2200 evo
15
版本 3.0
概要目录
安全提示 — 第章 2
© 2012 Datacon Technology GmbH
版本 3.0
16
2200 evo
安全提示 — 第章 2
绪论概要
绪论
本章发布
• 使用此机台的概括信息及相关内容。 • 机台的处理。
© 2012 Datacon Technology GmbH
2200 evo
9
版本 3.0
认证目录
安全提示 — 第章 1
© 2012 Datacon Technology GmbH
版本 3.0
10
2200 evo
安全提示 — 第章 1
绪论绪论

SAE J1772-2012

SAE 技术标准局的规章制度规定：本报告由SAE 出版，目的在于改进技术与工程科学的现状。

本报告的使用出于完全自愿的原则，且其对任何特殊用途的适用性，包括由此产生的专利侵权，均由使用者自行承担。

SAE 至少每五年对每份技术报告进行一次审查，在此期间可能重新订正、修订或撤销。

SAE 期待您的书面意见和建议。

除非另行规定，否则未经SAE 事先书面许可，不得以任何形式或通过任何电子、机械、影印或记录方式复制、储存于检索系统中或传播本出版物的任何部分。

文件订购：电话： 877-606-7323（美国和加拿大境内）电话： +1 724-776-4970（美国境外）传真： 724-776-0790邮箱：Custome-rSe-rvice-@网址：http://www SAE 期待您的建议。

登陆http:/technical/standards/J1772 201202提出关于本报告的反馈意见。

直流充电的接口目前正在研发中并在完成后增补在本文件中。

根据电荷等级，采用多种标准的充电接口以便选择符合汽车要求的适当充电接口，因此考虑更佳汽车包装、成本降低并易于用户使用。

根据2012年1月版中汽车与设备制造商的反馈意见，本版本包括技术和评论说明。

前言电池中储存的能量为电动汽车（EV ）或插电式混合动力电动汽车（PHEV ）提供动力。

传导式充电将供电网连接至EV/PHEV ，目的在于传输能量，以供电池充电并运行汽车的其他电气系统，同时形成了可靠的设备接地路径，并在EV/PHEV 与供应设备之间交换控制信息。

P-STAR服务准则(2012版)__第二章新契约业务服务规范

平安人寿业务人员P-STAR服务准则（2012版）第二章新契约业务服务规范第十二条新契约业务办理业务人员在展业过程中应当严格依据公司《基本法》要求执行，规范个人销售行为，开展健康的新契约业务，提供诚信良好的新契约服务。

一、不得使用未经公司核准的建议书、产品说明书及其他展业资料，不得向客户提供虚假资料或误导性的宣传说明，不得曲意解释条款、投保规则、产品说明书等，不得擅自修改、变更投保书，不得擅自提高、降低保险费率，不得向客户夸大或承诺投资收益、分红红利、夸大资金投资渠道、保险保障利益，不得向客户隐瞒投资风险事实、投资账户保费分配方式、公司向客户收取的投资账户的各项费用以及收取比例。

二、向个人销售新型产品，应当向投保人出示保险条款、产品说明书以及投保提示书。

订立保险合同，须向投保人说明合同的内容，包括产品保障的范围和保险金额，缴费期间和金额，限制条款及免责条款等，不得遗漏、隐瞒、夸大上述事项。

个险投保单应当包含投保人确认栏，并由投保人抄录下列语句后亲笔签名：“本人已阅读保险条款、产品说明书和投保提示书，了解本产品的特点和保单利益的不确定性”。

业务人员向投保人提供投保单时应当附保险合同条款，并提醒投保人在投保单上填写准确的通讯地址、联系电话等信息。

三、根据反洗钱的相关规定开展新契约业务，展业过程中对客户进行甄别，对达到反洗钱标准的新契约按照监管要求负有搜集相关资料的责任。

四、不得协同客户提供不完整、不真实的健康检查报告，不得协同客户让他人顶替健康检查、伪造或修改健康检查报告、或明知客户提供虚假健康信息却不告知公司，不得擅自找他人顶替健康检查，提供虚假健康检查报告。

五、在递交投保申请时或应缴月前及时提醒客户在账户内存入足额保费，并避免因银行扣除小额账户管理费、其他保单扣款等原因造成客户存入足额保费后余额仍不足交纳本次应交保费。

六、不得以获取公司预收政策奖励为目的，提供非公司、客户原因导致无法有效承保的投保单。

ISO 11640--2012 皮革色牢度试验往复式反复摩擦色牢度

ISO 11640:2012(E) IULTCS/IUF 450:2012(E)
COPYRIGHT PROTECTED DOCUMENT
© ISO 2012 All rights reserved. Unless otherwise specified, no part of this publication may be reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying and microfilm, without permission in writing from either ISO at the address below or ISO's member body in the country of the requester. ISO copyright office Case postale 56 CH-1211 Geneva 20 Tel. + 41 22 749 01 11 Fax + 41 22 749 09 47 E-mail copyright@ Web Published in Switzerland
Cuir — Essais de solidité des coloris — Solidité des coloris au frottement en va-et-vient
Reference number ISO 11640:2012(E) IULTCS / IUF 450:2012(E)
© ISO 2012
INTERNATIONAL STANDARD
ISO 11640

NQF BTECs 2012和2013年度后结果服务 January 2014 内容说明书

NQF BTECs from 2012 and 2013Post results services January 2014Contents1.Service Types (3)1.1.EAR Service 1: Clerical check (3)1.2.EAR Service 2: Post-results review of marking of externally assessed units (3)1.3.EAR Service 2 (2P: Post-results review of marking of externally assessed units .3 1.4.EAR Service 3: Post-results review of moderation of internallyassessed/externally moderated coursework units (3)1.5.Access to Scripts Services (4)1.6.Extensions to Enquiries About Results (5)1.7.Appeals (5)2.How to apply for Post-Results Services (7)2.1.For On-screen on demand tests (7)2.2.For all other externally assessed unit types (8)3.Submission deadlines (13)3.1.On-screen on demand (13)3.2.Timetabled, Paper-based exams (13)4.Turnaround and fees (14)5.Services available - by unit (15)1.Service Types1.1.EAR Service 1: Clerical checkThis service constitutes a check of all clerical procedures which lead to the issue of a result. This service might be considered when anomalous results have been issued for one learner, compared to the rest of the cohort.This service includes a check on the following:•all parts of the test have been marked•the totalling of marks•the recording of marks•the application of any adjustments•the application of grade thresholdsLearners’ grades can go up or down.1.2. EAR Service 2: Post-results review of marking of externally assessedunitsThis service will include:•the clerical re-check (Service 1)•the review of marking of the unit by a senior examiner•if requested, a copy of the reviewed script(s) for those units included in ATS. A fee is levied for this additional service.Learners’ grades can go up or down.1.3.EAR Service 2 (2P: Post-results review of marking of externallyassessed unitsThis post-results review of marking service offers the same services as outlined above but we aim to complete the enquiry within 18 days of acknowledging the request.This service is only available if the following criteria are met:•the enquiry is about a Level 3 unit• a learner’s place in further/higher education depends on the outcome•applications must be submitted before the deadline to receive Priority Service 2 applications.All applications not meeting the above criteria will be treated as normal Service 2 requests.This service is only available for the June examination series.1.4.EAR Service 3: Post-results review of moderation of internallyassessed/externally moderated coursework unitsThis service constitutes a review of moderation of a centre’s coursework by a senior moderator. The service is not available to individual learners.Please note that learners’ marks may be lowered following a review of moderation, but their published unit grades will NOT be lowered in the series concerned. However,centres should be aware that a lowered mark may be carried forward to future certification.The review of moderation will:•be undertaken on the original sample of learners’ work and will replicate the original moderation procedure•not be undertaken for the work of an individual learner or for the work of learners not in the original sample•include feedback similar to that provided following the original moderation•not be undertaken when the centre’s marks were accepted at the original moderation.1.5.Access to Scripts ServicesDue to the nature of onscreen, on demand testing the ‘Access to Scripts’ (ATS) service is not available for any onscreen, on demand test.Where possible, the ATS service is available for all NQF BTEC externally assessed components.Please check the table of services at the end of this section of the manual for component availability before completing an ATS request.Once scripts have been despatched, or electronic copies of scripts in a PDF format have been made available, they cannot be returned to Pearson with a request for a refund. Copied scriptsCopied scripts are available to allow centres to make a decision on whether to submit an EAR Service 2 request.Please note that these advance copy services are NOT available if requesting Priority Service 2 Enquiries About Results. If a learner requests a Priority Service 2 Enquiry About Results, an application for a photocopy script must not be made. Centres should progress straight to a Priority Service 2 Enquiry About Results.Copies of reviewed scriptsIf requested, a copy of the reviewed script(s) for those units included in the Access to Scripts service can be made available once the post-results review of marking is complete. This will include any annotations that may have been made by the examiner when reviewing the script.This request needs to be made at the same time as the Enquiry About Results is made. This can be done by ticking the ‘ATSPE’ box when submitting your request.A fee is levied for this additional service.Original scriptsAn original script service is available for all units with an ATS facility.Please note that Pearson cannot provide original scripts for papers that were marked online. Instead, an electronic copy of the script in PDF format will be made available to the centre.Once an original script has been returned to a centre its security is compromised and it can no longer be subject to an enquiry or investigation.Original scripts/PDFs will not be made available to centres before the deadline for receipt of Enquiries About Results. Centres may, however, request copies of reviewed scripts at the same time as requesting an Enquiry About Results.Where appropriate, examiners may write comments on traditionally marked scripts indicating the way in which learners have met the requirements of the marking scheme. Examiners are asked to refer scripts to a more senior examiner where they are doubtful about how to apply the mark scheme. A script might have a note to that effect.Scripts marked online do not show any comments when they are returned to centres.1.6.Extensions to Enquiries About ResultsWhere Pearson is satisfied that an EAR has revealed a demonstrable trend of significant under-marking of a centre cohort, it will seek to address the issue via an ‘extended review of marking’. Such an extended review of marking may take one of the following courses of action as appropriate:• a partial extended review of marking of learners’ entire scripts, or of selected questions or sections of a paper• a total extended review of marking of all learners in the centre cohort• a statistical adjustment to the raw marks of the remaining learners.Pearson monitors the outcome of all EARs. However, if a centre feels there is a demonstrable trend of significant under-marking on a paper it must raise the matter with Pearson within 14 days of the receipt of the last relevant review of marking result confirmation.Pearson will authorise an extended review of marking only if it accepts that a demonstrable trend of significant under-marking has been revealed. ‘Significant under-marking’ is generally defined as a change of more that 5% of the total raw mark for the paper.We hold the following criteria in mind when deciding upon an extended review of marking:•review of marking evidence is required from paid requests from a representative sample of 10%of the centre’s cohort•the sample should be a minimum of eight learners. In the case of very large centre entries where 10% would be more than 20, centres need not submit more than 20 requests for reviews of marking•at least 50% of the reviewed sample must have experienced significant under-marking•unit grade changes will not be used as a criterion to determine whether an Enquiry About Results should be extended•the evidence of one EAR cannot be accepted as a trend.Where Pearson initiates an extended review of marking, learners’ marks and unit grades may only be confirmed or raised; marks and subject grades will not be lowered. Where Pearson initiates an extended review of marking centres will not be charged a fee. Where Pearson initiates an extended review of marking centres will not be invoiced for those reviews requested as part of the ‘representative sample’.1.7.AppealsFollowing receipt of the outcome of an EAR, the centre may wish to appeal against the decision if they remain dissatisfied. The head of centre (or designated member of the centre’s senior management team or examinations manager) will be allowed 14 calendar days from the receipt of the outcome of the EAR during which an appeal may be lodged by writing to the following address:Pearson UK Appeals OfficeOne90 High Holborn LondonWC1V 7BH*************************************.Appeals cannot be accepted directly from learners, their parents or other third parties acting on their behalf. However, private learners may appeal directly without the support of the entering centre.Appeals may only be lodged on the basis of whether the awarding body used procedures which were consistent with the regulatory authorities’ Code of Practice, and applied its procedures properly and fairly in arriving at judgements. The appeals office may refuse to accept an appeal if no procedural grounds are specified.The procedures which are open to investigation include the full range of processes involved in and leading to the award of grades: the setting of papers; marking and moderation; the grade award and EARs and administrative arrangements.Note: The appeals process is not directly concerned with making judgements about the quality of learners’ work, as this is the responsibility of senior examiners and moderators. Appeals do not normally involve the further review of marking or moderation of work, unless the initial appeals investigation suggests that procedures were not followed during the EAR.Centres may also appeal against decisions taken by Pearson concerning special consideration cases, including cases where an aegrotat award has been made, and access arrangements. In these cases, the centre may contact the appeals office directly, without first requesting an EAR.When an appeal is lodged, Pearson will carry out a preliminary appeals investigation. This will take the form of a fresh examination of all available evidence and may involve research officers, subject-related assessment staff and senior examining personnel. The EAR files and other relevant records will also be inspected for accuracy.Each letter of appeal will be acknowledged within two working days of receipt, at which time further written guidance on the Pearson appeals process will be provided. A letter, summarising the results of the initial appeals investigation, will normally be sent within 21 calendar days of receipt of the letter of appeal. In the event that the appeals office is unable to complete its enquiries within 21 days the centre will be advised of the likely extent of any delay.If, following the initial investigation, the centre remains dissatisfied with Pearson’s response, the head of centre may request the opportunity to present the case in person at a hearing of the Pearson appeals panel. If, following an appeal hearing, the centre remains dissatisfied, it may submit an appeal to the Examinations Procedures Review Service (EPRS). There is no fee for appealing.2.How to apply for Post-Results Services2.1.For On-screen on demand testsPlease note that Enquiries about Results (EAR) requests for On-screen on demand tests can only be submitted within 10 days of results being issued by sending an email to:*********************************You should check the table of services on page 16 before you apply, as not all services are available for each test type.The email needs to include the following information:•Centre number•Learner Registration number•Test/unit code•Date of testYou are advised to submit applications at the earliest opportunity, as applications cannot be made after the deadline. All Post Results applications received outside this window will not be accepted.2.2.For all other externally assessed unit typesPlease note that Enquiries About Results and Access to Scripts can only be submitted using Edexcel Online. Centres are advised to submit applications at the earliest opportunity, as applications cannot be accepted after the published closing date.All applications submitted will be automatically acknowledged online. If the acknowledgement is not available on the same day as the application is made, please contact Pearson immediately.For general Post-results Services and for querying Missing or Incomplete results (MIRs), please contact us on 0844 463 2535.How to use Edexcel Online to submit Post-results Services (PRS) requestsClick on the Post Results menu option.You will then be on the PRS Homepage.Select the ‘Make a PRS Request’ option to go to the ‘Post Results – New Request’ screen. Select the Series by using the drop down list. From the next drop down field, ‘Units filter’ select the Unit you need and then the required service from the ‘Service Type’ drop down list.Please note that, depending on the selected unit, the availability of the services may vary. For example an EAR2 is not available for a moderated unit and so will not be available for selection.Once all the filters have been selected, click the button.You will then be shown a list of learners at your centre who sat that unit; please note that if you request an EAR3 (a review of the moderation of the original sample of material), a list of the moderated learners will be shown. All learners will need to be selected for an EAR3, as you cannot request an EAR3 for an individual learner.Here is an example of the screen you will see showing the learners who sat a particular examination:Once you have the list of learners who sat a particular unit, you simply select the learner (or learners) for whom you want to apply for a particular PRS service. If you would like to add ATSPE (access to scripts post enquiry) service then use the check boxavailable on the screen.Finally, click the ‘Submit’ button.You will then be presented with your PRS selection. This screen allows you to check what you have requested before you either click on ‘Submit’ or ‘Cancel’.After clicking the Submit button, you will be presented with the Post Results –Confirmation screen.request. Please quote this number when you contact us if you have any questions about this request. The ‘Potential Cost’ and ‘Target Completion Date’ are also shown.To continue :to make another request clickto return to the main menu page clickto logout of the PRS system clickTracking the Progress of your request:To view your acknowledgement letter, the progress of your PRS request and theoutcome letter (once the review has been completed), select: from the Home page.You will then be shown a list of learners at your centre for whom a PRS request has been raised. The acknowledgement letter is accessible by the Download link in the letterThe Status column will inform you of the progress of the review.ACK = acknowledgedPRG = in progressCLD = closed.When the PRS request has the status of CLD, the outcome letter will be available for you to download from the Download link in the ‘Outcome’ column.3.Submission deadlines3.1.On-screen on demandRequests for Enquiries About Results (EAR) should be submitted within 10 days of the issue of Results.3.2.Timetabled, Paper-based exams5 March 2014 Issue of January 2014 results6 March 2014 EAR services available ATS service available10 April 2014 Last date for Pearson to receiveapplications for Enquiries AboutResults (January 2014examinations) Last date for Pearson to receive ATS requests4.Turnaround and feesService 1 — clerical check 20 days £10.30Service 2 — Post-results review of marking 30 days £27.00ATS — original script n/a £7.75ATS — photocopy Script n/a £10.30 / £2.50 forPerforming ArtsATS – post EAR photocopy script n/a £10.30Cancellation fee:If the cancellation of an EAR Service 2 Post-results review of marking is requested after processing of the EAR has begun but before the EAR is completed, there will be a cancellation fee equal to 50% of the original fee. If the cancellation request is received after completion of the EAR, the full fees shown above will apply.Waiving of EAR fees:Centres will not be invoiced if the EAR leads to a change in the unit grade for the learner.5. Services available - by unitThe following tables give details of the EAR services available for each unit.Notes either refer examination officers to general points that need to be considered in order to complete an EAR request successfully for a particular service, or they highlight subjects where subject-specific guidance should be referred to.1 2 320560E Unit 1: The Online World Onscreen test Y Y N N N N20562E Unit 2: TechnologySystems Onscreen test Y Y N N N N20586E Unit 1: Fitness for Sportand Exercise Onscreen test Y Y N N N N20498E Unit 2: Finance forBusinessOnscreen test Y Y N N N N21325E Unit 9: Principles ofMarketing Timetabled,paper-basedexaminationY Y N N Y Y20526E Unit 1: The EngineeringWorld Onscreen test Y Y N N N N21174E Unit 9: Interpreting andUsing EngineeringInformation Timetabled,paper-basedexaminationY Y N N Y Y20544E Unit 1: Human LifespanDevelopment Timetabled,paper-basedexaminationY Y N N Y Y20780E Unit 1: ChildDevelopment (Level 3National) Timetabled,paper-basedexaminationY Y N N Y Y16。

6月常规培训--1~20条常见Q&A--NC

第一批20个FAQ话术——NC 6月常规培训一，与喂养有关的FAQ：1宝宝腹泻，是否与奶粉质量有关?答：宝宝腹泻是妈妈最担心的，妈妈肯定很着急。

首先应详细了解小孩年龄、喂养方法、近两天的膳食情况、小孩的发病情况及目前状况。

建议小孩暂缓使用普通婴儿奶粉，同时选择特殊配方奶粉如安婴乐并及时就诊。

请妈妈放心，我们公司的每次产品出厂前都要经过非常严格的检验只有符合国家婴幼儿配方奶粉标准和我司内控标准的产品才能出厂。

如果没有保存不当的情况，产品保质期内的产品质量都是有保证的。

小孩的腹泻症状应与奶粉质量没有直接的关系。

2婴幼儿为什么容易溢奶、吐奶？怎样预防？答：0-6个月婴幼儿吃奶后出现吐奶，是很多妈妈经常碰到的，妈妈无需太担忧。

常见的呕吐原因很多，主要分生理性和病理性两种。

生理性原因：主要是新生儿的胃呈水平位置，如摄入的奶量过多或速度过快，吞入气体较多或过多翻动孩子（如换尿布）等，都会引起宝宝吐奶，随着宝宝长大，这种现象会消失。

奶粉本身是不会引起宝宝呕吐的。

病理性原因：原因很多，呕吐一般较剧烈，量多，有时呈喷射状，且多伴有精神差、摄奶量减少等情况，这时候应找医生诊治。

一般妈妈喂完奶后，需把宝宝抱起轻拍背部，令其打嗝儿，空气排出，就不会吐奶了，人工喂养者，注意奶头大小，喂奶速度都要合适，哭闹厉害时不要喂奶。

3母乳不足时，要添加奶粉，但BB不肯吃，怎么办？答：当母乳不足时，要给宝宝添加接近于母乳配方的奶粉，但宝宝不肯吃，这是妈妈是很担心的。

主要原因是宝宝吃惯母乳并习惯了母亲的乳头，在生理上和心理上对母亲有一种依恋，橡皮奶嘴相对比较硬，要他改用橡皮奶嘴和配方奶粉，就会表现为不愿吸吮奶瓶的奶头或不吃奶粉，造成喂养上的困难。

遇到这种情况，千万别心急，应给宝宝一段时间去适应，可以试试以下方法：每天定时在宝宝饥饿或睡觉不清醒时喂奶粉；开始应量少和较稀的浓度，适应后再慢慢增加奶量和次数；如不吸奶嘴，可用汤匙慢慢喂。

只要有耐心，坚持喂养，一定可以成功的4宝宝要每天喝多少奶量才合适？（怎么能知道孩子吃饱了？）答：妈妈你好细心啊，这是很多妈妈关心的。

ISO 14971 2012 附件

附件2-1使用下列根據EN ISO 14971:2012規定之問題答問方式來評估The identification of qualitative and quantitative characteristics was described by answering the following questions together with the information in annex C(EN14971:2007) of this clause:Basically the technique description for this model may be presented as the following Q & A.C2.1 What is the intended use/intended purpose and how is the medical device to be used? (醫療器械的預期用途是什麼?醫療器械如何使用?)C2.2 Is the medical device intended to be implanted? (醫療器械是否預期用於植入?)C2.3 Is the medical device intended to contact the patient or other persons? (醫療器械是否預期和患者或其他人接觸?)C2.4 What materials and/or components are incorporated in the medical device or are used with, or are in contact with, the medical device? (在醫療器械中用到了何種材料或部件? 或何種材料或部件與醫療器械共同使用,或與產品接觸?)C2.5 Is energy delivered to or extracted from the patient? (是否有能量給予患者或從患者身上獲取?)C2.6 Are substances delivered to or extracted from the patient? (是否有物質提供給患者或從患者身上提取?)C2.7 Are biological material processed by the device for subsequent re-used, transfusion or transplantation? (是否由醫療器械處理生物材料並用於再次使用、輸送或移植?)C2.8 Is the medical device supplied sterile or intended to be sterilized by the user, or are other microbiological controls applicable? (醫療器械是否以無菌形式提供或預期由使用者滅菌,或採用其他微生物控制方法?)C2.9 Is the medical device intended to be routinely cleaned and disinfected by the used? (醫療器械是否預期由用戶進行常規清潔和消毒?)C2.10 Is the medical device intended to modify the patient environment? (器械是否預期改善患者的環境?)C2.11 Are measurements taken? (是否進行測量?)C2.12 Is the medical device interpretative? (器械是否進行分析處理(解釋)?).C2.13 Is this medical device intended for use in conjunction with medicines or other medical technologies? (器械是否預期與其他器械,醫藥或醫療技術聯合使用?)C2.14 Are there unwanted output of energy or substances? (是否由不希望的能量或物質輸出?)C2.15 Is the medical device susceptible to environmental influences? (醫療器械是否對環境影響敏感?)C2.16 Does the medical device influence the environment? (醫療器械是否影響環境?)C2.17 Are there essential consumables or accessories associated with the device? (醫療器械是否有與之相關的基本耗材或附件?)C2.18 Is maintenance and/or calibration necessary? (是否有必要進行維護或校準?)C2.19 Does the medical device contain software? (醫療器械是否包括軟體?)C2.20 Does the medical device have a restricted shelf-life? (醫療器械是否有儲存壽命限制?)C2.21 Are there any delayed and/or long-term use effects? (是否有延遲或長期使用效應?) C2.22 To what mechanical forces may the medical device be subjected? (醫療器械承受何種機械力?)C2.23 What determines the lifetime of the medical device? (什麼決定醫療器械的壽命?)C2.24 Is the medical device intended for single use? (器械是否預期一次性使用?)C2.25 Is safe decommissioning or disposal of the medical device necessary? (器械是否需要安全的退出使用或處置?)C2.26 Does installation or use of the medical device require special training or special skill? (器械的安裝或使用是否需要經過專門培訓或專門的技能?)C2.27 How may information for safe use be provided? (安全使用資訊是如何提供的?)C2.28 May new manufacturing processes need to be established or introduced? (是否需要建立或引入新的生產過程?)C2.29 Is successful application of the medical device critically dependent on human factors such as the user interface? (醫療器械的成功使用,是否決定性的取決於人為因素,例如使用者介面?)C2.29.1 Can the user interface design features contribute to use error ? (用戶介面的設計特徵是否可能導致使用錯誤?)C2.29.2 Is the medical device used in an environment where distraction can cause the error ? (在器械的使用環境中, 是否會因分心而導致使用錯誤?)C2.29.3 Does the medical device have connecting parts or accessories? (醫療器械是否有連接部件或附件?)C2.29.4 Does the medical device with a control interface? (器械是否有控制介面?)C2.29.5 Does the medical device display information? (醫療器械是否顯示資訊?)C2.29.6 Is the medical device controlled by a menu? (醫療器械是否由功能表控制?)C2.29.7 May the medical device be used by persons with special needs? (醫療器械是否用於有特殊需要的人?)C2.29.8 Can the user interface be used to initiate user actions? (用戶介面是否可能使用戶開始行動?)C2.30 Does the medical device use an alarm system? (醫療器械是否使用警報系統?)C2.31 In what way(s) might the medical device be deliberately misused ? (在何種情況下醫療器械可能被有意的誤用?)C2.32 Does the medical device hold data critical to patient care? (醫療器械是否保存對患者護理非常重要的資料?)C2.33 Is the medical device intended to be mobile or portable? (醫療器械是否預期用為移動式或攜帶型?)C2.34 Does the use of medical device depend on essential performance ? (醫療器械的使用取決於其根本性能?)II.產品特性與危害源參考(Product characteristics & Hazards Exercise)：II.1 GeneralII.2 to II.7係由歐洲法規ISO-14971中的危害來源參考表取得II.2 能源危害(Energy hazards) □適用(Available)□不適用(Not available)項目(ITEM) 內容(CONTENTS) 適用不適用II.2-1 電器特性ElectricityII.2-2 熱源HeatII.2-3 機械力Mechanical forceII.2-4 離子幅射Ionizing radiationII.2-5 非離子性幅射Non-ionizing radiationII.2-6 電子磁場Electromagnetic fieldsII.2-7 移動性零件Moving partsII.2-8 懸吊量Suspended massesII.2-9 病人支撐裝置Patient support deviceII.2-10 壓力Pressure(vessel rupture)II.2-11 聲壓Acoustic pressureII.2-12 振動力VibrationII.3 生物性危害Biological hazards □適用Available □不適用Not available項目(ITEM) 內容(CONTENTS) 適用不適用II.3-1 生物負載&生物性污染Bio-burden & Bio-contaminationII.3-2 生物不相容性Bio-incompatibilityII.3-3 錯誤輸出Incorrect output ( substance /energy)II.3-4 錯誤規劃Incorrect formulation(chemical composition)II.3-5 毒性ToxicityII.3-6 (交互)傳染(cross-)infectionII.3-7 熱生成PyrogenicityII.3-8 無法維持衛生安全Inability to maintain hygienic safetyII.4 環境面危害Environmental hazards □適用Available □不適用Not available 項目(ITEM) 內容(CONTENTS) 適用不適用II.4-1 電磁干擾Electromagnetic interferenceII.4-2 動力或冷卻不足Inadequate supply of power or coolantII.4-3 冷卻限制Restriction of coolingII.4-4 室外操作時的環境狀態限制說明Likelihood of operation outside prescribed environmental conditionsII.4-5 與其它產品不相容性Incompatibility with other devicesII.4-6 意外機械損傷Accidental mechanical damageII.4-7 報廢產品的污染Contamination due to waste products and/or device disposalII.5有關使用的危害(Hazards related to the use of the device)□適用(Available)□不適用(Not available)項目(ITEM) 內容(CONTENTS) 適用不適用II.5-1 不適當的標籤Inadequate LabelingII.5-2 不適當的操作手冊Inadequate operating instructionsII.5-3 不適當的附件規格Inadequate specification of accessoriesII.5-4 過於複雜的操作手冊Over-complicated operating instructionsII.5-5 分散的操作手冊Unavailable or separated operating instructionsII.5-6 被非熟練的人使用Use by unskilled personnelII.5-7 被非受過訓練的人使用Use by untrained personnelII.5-8 人為錯誤Human errorII.5-9 不適當的邊際效應警告Insufficient warning of side effectsII.5-10 不適當的危害警告如重覆使用僅能單次使用的器械Inadequate warning of hazards likely with re-use of single use devicesII.5-11 不正確的量測Incorrect measurement and other metrological aspectsII.5-12 不適當的診斷Incorrect diagnosisII.5-13 錯誤的資料傳輸Erroneous data transferII.5-14 呈現錯誤結果Misrepresentation of resultsI.6功能故障,保養,老化所引起的危害(Hazard arising from functional failure,maintenance and aging): □適用(Available)□不適用(Not available)項目(ITEM) 內容(CONTENTS) 適用不適用II.6-1 產品特性不符適應症Inadequacy of performance characteristics for the intended use II.6-2 缺維修保養手冊Lack of specification for maintenanceII.6-3 不適當的維修保養Inadequately maintenanceII.6-4 沒有定義產品使用壽命Lock of adequate determination of end of device lifeII.6-5 零件缺失Loss of mechanical integrityII.6-6 不適當的包裝Inadequate packaging (contamination and/or deterioration ofthe device)II.7 其他(Others): 適用(Available)□不適用(Not available)項目(ITEM) 內容(CONTENTS) 適用不適用。

FDA《调查工作手册》中所遇到的缩略词

翻译美国FDA 《调查工作手册》中所遇到的缩略词(2012-04-09 10:13:58)转载▼分类：小百科标签：英语翻译fda调查工作手册缩略词最近，在忙一件翻译任务，翻译美国FDA的《调查工作手册》中的某些章节。

由于时间紧，任务重，以至于俺每晚都翻译到十一点，有天晚上甚至翻到半夜两点半（当然，主要是为了看半夜两点四十五分的欧冠联赛，呵呵。

但也因此肩膀酸痛，可能是肩周炎了，）。

在翻译过程中，遇到不少缩略词和缩写词。

其中有些在网上可以查到，有些则没有，需要联系上下文自行揣摩翻译。

现把俺自己的整理出来的缩略词表附上，以备不时之需。

ACRA：Associate Commissioner for Regulatory Affairs：日常事务办公室副主任AO：Administrative Officer：政务主任AOAC：Association of Official Analytical Chemists：美国公职分析化学家协会ASCII：American Standard Code for Informaition Interchange：美国信息交换标准码ATSDR：Agency for Toxic Substances and Disease Registry：有毒物质与疾病登记局BIMO：Bioresearch Monitoring：生物研究监测BSE：Bovine Spongiform Encephalopathy：疯牛病BTA：Bioterrorism Preparedness & Response Act：生物恐怖预防和应对法案CBER：Center for Biologics Evaluation & Research：生物制品评估研究中心CD-R：Compact Disk Recordable：CD盘CDER：Center for Drugs Evaluation & Research：药品评估研究中心CDRH：Center for Devices & Radiological Health：设备与放射卫生中心CFN：Central File Number：中心档案号CFP：Conference for Food Rrotection：食品保护协会CFR：Code of Federal Regulations：联邦法规法典CFSAN：Center for Food Safety & Applied Nutrition：食品安全和应用营养中心CGMP：Current Good Manufacturing Practice：动态药品生产管理规范CONUS：Continental United States：美国本土COPE：Coordinated Operations Plan for Emergencies：紧急情况协调行动计划CPG：Compliance Policy Guide：执行政策指南CPGM：Compliance Program Guidance Manual：执行项目指导手册C/R（CR）：Collection Report：取样报告CTP：Center for Tobacco Products：烟草制品中心CVM：Center for Veterinary Medicine：兽药中心DCIA：Division of Small Manufacturers，Consumer & International Affairs：小型企业、消费者和国际事务部DCIQA：Division Compliance Information and Quality Assurance：执行信息与质量保证部DCMO：Division of Compliance Management & Operations：执行管理行动部DCP：Division of Compliance Policy：执行政策部DD：District Director：地区主管DDFI：Division of Domestic Field Investigations：国内实地调查部DFFI：Division of Foreign Field Investigations：国外实地调查部DFOI：Division of Freedom of Information：信息自由部DFS：Division of Field Science：外勤科技部DFSR：Division of Federal-State Relations：与联邦-州关系部DHHS：Department of Health & Human Services：美国卫生与公共服务部DHRD：Division of Human Resource Development：人力资源开发部DIOP：Division of Import Operations and Policy：进口行动与政策部DMO：Division of Management Operations：运营管理部DO：District Office：地区办公室DOC：Documentary or Official：文件正式样品DOD：Department of Defense：国防部DSMICA：Division of Manufacturers，International and Consumer Affairs：制造商、国际和消费者事务部DVM：Doctor of Veterinary Medicine：兽医学博士EI：Establishment Inspection：实施检查EIR：Establishment Inspection Report：检查实施报告EO：Ethylene Oxide Gas：氧化乙烯气体EOC：Emergency Operations Center：紧急行动中心EPA：Environmental Protection Agency：环保局EPIC：Egg Products Inspection Act：蛋制品检查法案ERC：Emergency Response Coordinator：紧急应对协调员FACTS：Field Accomplishments & Compliance Tracking System：外勤业绩与执行追踪系统FDA：Food & Drug Administration：美国食品与药品管理局FDA3369：Daily Log of Government Vehicle：政府车辆使用日志表FDA464：Collection Report（CR）（C/R）：取样报告FDA482：Notice of Inspection：检查通知书FDA483：Inspectional Observations：检查观察通知书FDA484：Receipt for Samples：样品收据（表）FDAAA：Food & Drug Administration Amendments Act：食品与药品管理法修正案FDAMA：Food & Drug Administration Modernization Act：食品与药品管理现代化法案FD&C：Federal Food，Drug，and Cosmetic Act：联邦食品、药品与化妆品法案FEI：FDA Establishment Identifier：FDA注册识别号码FMD：Field Management Directive：外勤管理指令FOIA：Freedom of Information Act：信息自由法案FPS：Federal Protective Service：联邦保护局FR：Federal Register：联邦公报FSIS：Food Safety and Inspection Service：食品安全检验局FTR：Federal Travel Regulations：联邦旅行法规GCP：Good Clinical Practice：药品临床试验管理规范GGP：Good Guidance Practices：指导管理规范GIIT：Guide to International Inspections and Travel：国际检查和出差指导GLP：Good Laboratory Practice：良好实验室管理规范GMP：Good Manufacturing Practice：生产管理规范GOV：Government-Owned Vehicles：政府车辆GSA：General Services Administration：联邦政府总务管理局GSA-3155：Offense/Incident Report：过失/事故报告表GWQAP：Federal Medical Products Quality Assurance Program：联邦医疗产品质量保证项目HACCP: Hazard Analysis and Critical Conttol Point: 危害分析和关键控制点体系HBV：Hepatitis B Virus：乙肝病毒HFA-320：Division of Mnangement Programs：管理项目部HFA-615：Emergency Operations Center：紧急行动中心HFC-10：Office of Resource Management：资源管理办公室（ORM）HFC-100：Ofiice of Regional Operations：大区行动办公室（ORO）HFC-130：Division of Domestic Field Investigations：国内实地调查部（DDFI）HFC-140：Division of Field Science：外勤科技部（DFS）HFC-150：Division of Federal-State Relations：与联邦-州关系部（DFSR）HFC-170：Division of Import Operations and Policy：进口货物行动与政策部（DIOP）HFC-180：Prior Notice Center：预警中心（PNC）HFC-20：Division of Management Operations：运营管理部HFC-200：Office of Eenforcement：执行办公室（OE）HFC-230：Division of Complaince Policy：执行政策部（DCP）HFC-300：Office of Criminal Investigations：犯罪调查办公室（OCI）HFC-40：Division of Planning, Evalution and Management：规划、评估和管理部HFC-60：Division of Human Resource Development：人力资源发展部HFI-1：Assistant Commissioner for Public Affairs：公共事务办公室副主任HFI-35：Division of Freedom Information：信息自由部（DFOI）HFM-445：Division of Viral Products：病毒产品部HHS-481：Employee Claim For Loss or Damage to Personal Property：工作人员个人财产损失或损毁索赔书ICAM：International Cooperative Agreement Manual：国际合作协议手册ICH：International Conference On Harmonization：药品注射技术要求国际协调会IDM：Information Disclosure Manual：信息披露手册INV：Inventory Management：库存管理IOB：International Operations Branch：国际行动分部IOM：Investigation Operations Manual：调查工作手册ISSC：Interstate Shellfish Sanitation Conference：州际贝类卫生协会ITG：Inspection Technical Guide：检查技术指导LACF：Low Acid Canned Foods：低酸罐装食品LIB：Laboratory Information Bulletin：实验室信息通报LPM：Laboratory Procedures Manual：实验室流程手册M&IE：Meals and Incidental Expenses：食杂费MDUFMA：Medical Device user Fee & Modernization Act：医疗设备使用收费与现代化法案MDQS：Medical Device Quality System：医疗设备质量管理体系MOA：Ministry of Agriculture：农业部MOU：Memoranda of Understanding：谅解备忘录MPH：Master of Public Health：公共卫生学硕士MQSA：Mammography Quality Standard Act：乳腺X射线摄影质量标准法案MRA：Mutual Recognition Agreement：相互承认协议MSDS：Material Safety Data Sheets：原料安全数据板NCIMS：National Conference on Interstate Milk Shipments：州际奶品贸易全国协会NDA：New Drug Application：新药申请规范NDA：Non-Discloure Agreement：保密协议NIST：National Institute of Standards & Technology：国家标准技术研究所NTEU：National Treasury Employees Union：国家财政员工工会NTIS：National Technical Information Service：国家技术情报服务处OA：Office of Administration：行政办公室OASIS：Operational and Administrative System for Import Support：支持进口运作和管理系统OBA：Oxygen Breathing Apparatus：氧气呼吸器OC：Office of Commisioners：主任办公室OCC：Office of Chief Counsel：首席律师办公室OCI：Office of Criminal Investigations：犯罪调查办公室OE：Office of Enforcement：执行办公室OEI：Official Establishment Inventory：单位正式注册清单OFM：Office of Financial Management：财务管理办公室OFS：Office of Financial Services：财务服务办公室OIA：Office of Internal Affairs：内务办公室OIM：Office of Information Management：信息管理办公室ORA：Office of Regulatory Affairs：日常事务办公室ORM：Office of Resource Management：资源管理办公室ORO：Office of Regional Operations：大区行动办公室OS：Official Sample：法定样品OSHA：Occupational Safety & Health Administration：职业安全卫生管理局PAC：Program Assignment Code：任务程序代码PAIRS：Public Affairs Reporting System：公共事务报告系统PAS：Public Affairs Specialist：公共事务专家PAT：Process Analytical Technology：加工分析技术规范PEL：Permissible Exposure Limit：允许暴露限制规定PHS：Public Health Services Act：公共卫生服务法案PMA：Pre-Market：上市之前PNC：Prior Notice Center：预警中心POC：Point of Contact：联系点POV：Privately Owned Vehicle：私家车PPIA：Poultry Products Inspection Act：禽类制品检查法案PSC：Program Support Center：项目支援中心QMS：Quality Management System：质量管理系统RFDD：Regional Food & Drug Director：大区食品与药品管理局局长RFR：Reportable Food Registry：可疑食品注册RMP：Regulatory Procedures Manual：管理流程手册SAFES：State Advisory Fax/Email System：国家传真/电子邮件报告系统SBR：Small Business Representative：大区小型公司代理员SBREFA：Small Business Regulatory Enforcement Fairness Act：小型公司监管和执法公平法案SCBA：Self-Contained Breathing Apparatus：自主式呼吸器SF-91：Motor Vehicle Accident Report：机动车辆事故报告书SF-94：Statement of Witness：目击报告SF-95：Claim for Damage，Injury or Death：对损毁、受伤或死亡的索赔书SMG：Staff Manual Guide：员工手册指南SOP：Standard Operation Procedures：标准操作（作战）程序（规范）（规定）SQL：Structured Query Language：结构化查询语言SSN：Social Security Number：社会保险号TA：Travel Authorization：出差批准书TMC：Travel Management Center：旅行管理中心UFMS：Unified Financial Management System：联合财务管理系统U.S.C.：United States Code：美国法典USP：United States Pharmacopoeia Convention：美国药典公约VWA：Voluntary Work Agreement：志愿工作协议WEAC：Winchester Engineering & Analytical Center：温彻斯特工程分析中心。

微软系统中心2012 R2 许可数据表单产品概述说明书

System Center 2012 R2 Licensing DatasheetProduct OverviewMicrosoft System Center 2012 R2 offers solutions for managing datacenter resources, private clouds, and client devices.Private Cloud/Datacenter Management System Center 2012 R2 helps your organization achieve IT as a Service by enabling:∙Productive infrastructure: Deliver flexible, cost-effective private-cloud infrastructure to your business units in a self-service model, while carrying forwardyour existing data center investments.∙Predictable applications: Deep application insight combined with a “service-centric” approach helps you deliver predictable application-service levels.∙Cloud computing on your terms: Deliver and consume private and public cloud computing on your terms with common management experiences across your hybrid environments.Client ManagementSystem Center 2012 R2 helps IT empower people to use the devices and applications they need to be productive, while maintaining corporate compliance and control. Licensing OverviewSystem Center 2012 R2 is licensed by:∙License required only for endpoints being managed. No additional licenses are needed formanagement servers or SQL Server technology.∙Consistent licensing model across editions.Processor-based license, covering up to twoprocessors for server management. User- or OSE-based license for client management. Licensing Managed Servers System Center 2012 R2 server management licensing maximizes your private cloud value while simplifying purchasing. All server management licenses (SMLs) include the same components and the ability to manage any workload.System Center 2012 R2 SMLs will be released in two editions differentiated by virtualization rights only:∙Datacenter: Maximizes cloud capacity with unlimited virtualization for high density private clouds∙Standard: For lightly or non-virtualized private cloud workloads.Server ML Edition Comparison:separately.Determining the Number of Licenses NeededServer MLs are required for managed devices that run server Operating System Environments (OSEs). Licenses are processor-based, with each license covering up to two physical processors. The number of Server MLs required for each managed server is determined by the number of physical processor in the server for Datacenter Edition and either number of physical processors in the server or number of OSEs being managed for Standard Edition (whichever is greater). If you choose the Standard Server ML, you can add more licenses to a server to manage a greater number of virtual OSEs.Multiple System Center 2012 R2 Standard licenses may be assigned to the same server to license the number of managed OSEs. Components included in the Server MLs are not available separately.Flexibility to License Managed OSEs Running on Public Cloud PlatformsAll System Center 2012 R2 Server Management Licenses with active Software Assurance qualify for License Mobility through Software Assurance benefits. With the License Mobility through Software Assurance benefit, you can assign Server MLs to manage applications running on a public cloud infrastructure.For more information, see the Microsoft License Mobility through Software Assurance Customer Guide .Transitioning to the New Server Licensing ModelIf you have Software Assurance coverage on your current System Center licenses at the time of System Center 2012 R2 General Availability, you will receive the following System Center 2012 R2 Server ML grants listed below:You may migrate from System Center 2012 R2 Standard to System Center 2012 R2 Datacenter by purchasing a Step-Up License.Licensing Managed ClientsClient Management Licenses (MLs) are required for managed devices that run non-server OSEs. There are three System Center 2012 R2 Client ML offerings:Client MLs are available on a per-OSE or per-user basis. Components included in the Client MLs are not available separately.Transitioning to the New Client Licensing ModelIf you have Software Assurance coverage on your current System Center licenses at the time of System Center 2012 R2 General Availability, you will receive the following System Center 2012 R2 Client ML grants listed in the following table:Planning for System Center 2012 R2If you are planning to deploy System Center 2012 R2, either through upgrades or new licenses, please remember: ∙Renewing Software Assurance (SA) is the best way to protect investments and provide access to newversions as well as Deployment Planning Services and technical assistance.∙Select your edition of System Center 2012 R2 based on virtualization rights:o Datacenter Edition for highly virtualizedprivate clouds o Standard Edition for lightly or non-virtualizedprivate clouds∙Core CAL and Enterprise CAL Suites will continue to be the most cost effective way to purchase client management products.∙Find out how flexible payments can help you get the IT you need and stay on budget.Visit /financing for program details or to learn more. Or contact your Microsoft Solution Partner directly or by calling 1-800-936-3500 in the United States and Canada.Frequently Asked Questions (FAQ)System Center 2012 R2 Server ManagementQ: What's new in System Center 2012 R2 server management licensing?A: System Center 2012 R2 server management licensing does not change from System Center 2012. Q: Can you describe the product editions offered with System Center 2012 R2?A: Same as System Center 2012, System Center 2012 R2 server management licenses will be released in 2 editions differentiated by virtualization rights only:∙Datacenter: Maximizes cloud capacity with unlimited Operating System Environments (OSEs) for high density private clouds∙Standard: For lightly or non-virtualized private cloud workloads.There is no differentiation between the types of workloads you can manage with either edition. The only difference between the editions is the number of Operating System Environments (OSEs) that you can manage per license. Datacenter Edition allows the management of an unlimited number of OSEs per license. Standard Edition allows the management of up to two OSEs per license.Q: How do I determine the number of Server Management Licenses (MLs) I need?A: Server MLs are required for managed devices that run server OSEs. Licenses are processor-based, with each license covering up to two physical processors. The number of Server MLs required for each managed server is determined by the number of physical processors in the server for Datacenter Edition and either number of physical processors in the server or number of OSEs being managed for Standard Edition (whichever is greater).∙System Center 2012 R2 DatacenterEach license covers up to two physical processors, so you must count the number of physicalprocessors on the server, divide that number by two, round up to the nearest whole number,and acquire and assign that number of licenses to your server.Provided you acquire and assign to your server the required number of Datacenter editionserver management licenses, as described above, you may manage any number of OSEs onthat server.∙System Center 2012 R2 StandardFor each managed server count the number of physical processors and the number ofmanaged OSE's. You need the number of licenses to cover the greater number (processors orOSE's).device. In that case, you only count the number of virtual OSEs you will manage on the server, divide that number by two, and round up to the nearest whole number.Examples:*Multiple System Center 2012 R2 Standard licenses may be assigned to the same server to license the number of managed OSEs.Q: Can I purchase each of the System Center 2012 R2 Server Management License components separately?A: No. The System Center 2012 R2 Server Management components are part of an integrated offering to create and manage private cloud environments and are available only as part of System Center 2012 R2 Standard and System Center Datacenter MLs.Q: Can I split 2012 R2 Server MLs across multiple servers?A: No, a single Server ML may not be used to license two one-processor servers.Q: Can I assign more than one System Center 2012 R2 Standard license to the same server to increase the number of OSEs I may manage?A: Yes. The breakeven point for moving to SC 2012 R2 Datacenter is 7 VMs per host.Q: How much do the Server MLs cost?A: The Microsoft Volume Licensing Open License No Level (NL) U.S. Estimated Retail Price (ERP) is $1,323 for System Center 2012 R2 Standard and $3,607 for System Center 2012 R2 Datacenter. For your specific pricing, contact your Microsoft reseller. Actual prices may vary. Microsoft does not determine pricing or payment terms for licenses acquired through resellers.Q: Can I extend a Server ML to manage applications running on the public cloud?A: Yes, with the License Mobility through Software Assurance benefit, you can assign Server ML to manage applications running on a public cloud infrastructure. System Center 2012 R2 Standard licenses allow you to manage two virtual OSE in a public cloud, while System Center 2012 R2 Datacenter licenses allow you to manage up to eight virtual OSEs in a public cloud. When managing applications running on Azure, each Azure instance is considered to be one virtual OSE. For more information, see the Microsoft License Mobility through Software Assurance Customer Guide.。

药品研发期间安全性更新报告要求及管理规定

研发期间安全性更新报告要求及管理规定1（公开征求意见稿）23第一章前言4第一条（制定依据及目的）《药品注册管理办法》要5求申请人在获准开展临床试验后，应当定期向国家局药品审6评中心提交研发期间安全性更新报告（以下简称“DSUR”）。

7为规范DSUR的编写与递交，制定本管理规范。

8第二条（强调报告的目的）DSUR的主要目的是每9年定期获取药物相关的全面的安全性信息。

它不应作为新的10重要安全性信息的初始报告途径，也不应作为新的安全性问11题的检出途径。

12第三条（适时修订）本管理规定是基于目前对13DSUR的认识而制定。

随着申请人对研发期间安全性信息定14期总结分析的经验积累及科学技术的不断发展，本管理规范15也将适时调整。

16第二章基本原则17第四条（编写基础）申请人应按照人用药品注册技18术要求国际协调会（以下简称“ICH”）E2F 《研发期间安全性19更新报告》的要求编写DSUR。

20第五条（单一活性成分）申请人在准备DSUR时，21需要包含与所有剂型和规格、所有适应症以及研究中接受研22究药物的患者人群相关的数据（化学药物和生物制品按照相23同活性成分准备，中成药按照相同处方准备）。

如果相关信24息无法获得（例如申请人尚未获得数据），应在DSUR的前25言部分予以解释说明。

26第六条（递交范围）申请人获准开展的药物( 包括27中药、化药和生物制品) 注册申请相关的Ⅰ、Ⅱ、Ⅲ期临床试28验，批件中有特别要求的Ⅳ期临床试验，承诺性临床试验，29已上市产品需要开展临床试验而申请增加新的人群或新的30适应症，以及已上市产品有重大变更或改变需要开展临床试31验的（如新剂型、新给药途径、新生产工艺），均应向国家32局药品审评中心递交DSUR。

33第七条（报告起算日）DSUR原则上应于药物临床34试验在境内获准的或在全球首次获得临床试验许可的日期35（即“国际研发诞生日”，以下简称"DIBD"）的月和日，作为年36度报告周期的起算日。

WS2012_Licensing-Pricing_Customer_FAQ_CN

Windows Server 2012 许可与定价常见问题目录WINDOWS SERVER 2012 许可与定价常见问题 (1)Q1.Windows Server 2012 有什么新功能？ (3)Q2.Windows Server 2012 标准版与 Windows Server 2012 数据中心版之间有什么区别？ (3)Q3.Windows Server 2012 标准版是否与 Windows Server 2012 数据中心版有着相同的功能？ (3)Q4.Windows Server 2012 是否可加入 System Center 2012 以及Enrollment for Core Infrastructure (ECI) 模型？ (3)Q5.目前 Windows Server 2012 标准版所包含的功能哪些是只能用于 Windows Server 2008 R2 企业版和数据中心版的？ (3)Q6.我该如何决定哪个 Windows Server 2012 版本更适合我？ (4)Q7.如果我有一个 Windows Server 2012 标准版许可，是否可以扩展我的虚拟化权力？ (4)Q8.为什么 Windows Server 2012 的许可转为处理器模式？ (5)Q9.如何计算一台服务器需要的许可数量？ (5)Q10.我能否在一颗处理器的服务器上使用一个标准版许可？ (6)Q11.我能否将 Windows Server 2012 许可分摊给多台服务器使用？ (6)Q12.我能否将 Windows Server 2012 许可分配给虚拟机？ (6)Q13.我能否在一台服务器上混用数据中心版与标准版许可？ (6)Q14.如果我希望使用老版本或其他 SKU 的软件，有什么办法？ (6)Q15.Windows Server 2012 是否不再提供企业版，为什么？ (6)Q16.Windows Server 2012 是否不再提供 Web Server，为什么？ (7)Q17.Windows Server 2012 是否不再提供 HPC 产品，为什么？ (7)Q18.如果我在 Windows Server 2012 正式发布时具备有效软件保障协议，什么时候我的许可记录中才会得以反应？ (7)Q19.如果在 Windows Server 2012 发布时，我有带软件保障的数据中心版本，那么我可以获得哪个版本？ (7)Q20.如果在 Windows Server 2012 发布时，我有带软件保障的企业版版本，那么我可以获得哪个版本？ (7)Q21.如果在 Windows Server 2012 发布时，我有带软件保障的标准版，那么我可以获得哪个版本？ (8)Q22.如果常规的软件保障转换无法涵盖我服务器中的所有处理器，我是否需要购买额外的许可？ (8)Q23.如果在 Windows Server 2012 发布时，我有带软件保障的 Web Server 版本，那么我可以获得哪个版本？ (8)Q24.如果在 Windows Server 2012 发布时，我有带软件保障的 HPC 版本，那么我可以获得哪个版本？ (8)Q25.通过微软采购项目，我可以获得怎样的软件保障迁移权力？ (9)Q26.Windows Server 2012 标准版与数据中心版售价如何？ (9)Q27.我能否使用 Windows Server 2008 CAL 访问 Windows Server 2012？ (10)Q28.我是否需要独立的 CAL 才能访问远程桌面服务（RDS）与 Active Directory 权限管理服务（ADRMS）？ (10)Q29.对于老版本 Windows Server，还有哪些支持可用？ (10)Q30.Windows Server 2012 Essentials 是什么？ (11)Q31.Windows Server 2012 Essentials 中可用的功能都有哪些？ (11)Q32.Windows Server 2012 Essentials 有哪些不同版本可用？ (11)Q33.是否会有下一版 Windows Small Business Server 2011 标准版？ (11)Q34.是否会有下一版 Windows Small Business Server 2011 高级加载项？ (11)Q35.如果在 Windows Server 2012 发布时，我有带软件保障的Windows Small Business Server 2011 Essentials，那么我可以获得哪个版本？ (12)Q36.如果在 Windows Server 2012 发布时，我有带软件保障的Windows Small Business Server 2011 标准版，那么我可以获得哪个版本？ (12)Q37.如果在 Windows Server 2012 发布时，我有带软件保障的Windows Small Business Server 2011 高级加载项，那么我可以获得哪个版本？ (12)Q38.Windows Server Essentials 售价如何？ (12)Q39.作为 Windows Server 2012 的一部分，Foundation 版的许可是否有任何变化？ (12)Windows Server 2012数据中心与标准版Q1.Windows Server 2012有什么新功能？Windows Server 2012 将我们公司在构建与运作公共云方面积累的经验带到了私有云服务器平台。

Microsoft 批量许可产品使用权利

Microsoft 批量许可产品使用权利简体中文 | 2014 年 1 月目录简介 (4)一般许可条款 (7)定义7您的使用权利8使用其他版本的权利8第三方软件8预发行代码8更新和补充8无商业托管服务8技术限制8其他权利8文档9软件外包管理9许可的重新分配9产品激活9附加功能/可选服务10结合使用多种产品或功能10字体组件10 Windows 软件组件10基准测试10包含 SQL Server 技术的产品10 SQL Server Reporting Services 地图报告项目10多路技术11 System Center 包11可分发代码11软件附加服务12创建和存储实例12不得分离软件12桌面应用程序（每设备） (13)Access 2013 13 AutoRoute 2013 14 Excel 2013 14 Excel for Mac 2011 14 InfoPath 2013 14 Lync 2013 14 Lync for Mac 2011 14 MapPoint 2013 Fleet Edition 15 MapPoint 2013 Standard Edition 15 Office for Mac Standard 2011 15 Office Home & Student 2013 RT 商业使用权利16 Office 多语言包 2013 16 Office Professional Plus 2013 16 Office Standard 2013 16 OneNote 2013 17 Outlook 2013 17 Outlook for Mac 2011 17 PowerPoint 2013 17 PowerPoint for Mac 2011 17 Project Professional 2013 17Project Standard 2013 18 Publisher 2013 18 Rental Rights for Office 18 Streets & Trips 2013 18 Visio 2013 Professional 18 Visio 2013 Standard 19 Word 2013 19 Word for Mac 2011 19桌面操作系统（每副本每设备） (20)Rental Rights for Windows 21 Windows 8.1 Pro 和 Windows 8.1 Enterprise 21 Windows Embedded 8.1 Industry 22服务器：处理器/CAL（处理器许可 + CAL + 可选外部连接器） (23)Windows Server 2012 R2 Datacenter 24 Windows Server 2012 R2 Standard 25服务器：服务器 / CAL（服务器许可 + CAL + 可选外部连接器） (27)Business Intelligence Appliance 2012 27 Exchange Server 2007 Standard for Small Business 28 Exchange Server 2013 Enterprise 29 Exchange Server 2013 Standard 29 Forefront Identity Manager 2010 R2 30 Forefront Unified Access Gateway 2010 31 Lync Server 2013 31 Microsoft Dynamics AX 2012 R2 32 Microsoft Dynamics CRM 2013 Server 33 Microsoft Office Audit and Control Management Server 2013 33 Project Server 2013 34 SharePoint Server 2013 34 SQL Server 2012 Business Intelligence 35 SQL Server 2012 Enterprise 36 SQL Server 2012 Standard 36采用 SQL Server 2012 技术的 Visual Studio Team Foundation Server 2013 36 Windows MultiPoint Server 2012 Premium 37 Windows MultiPoint Server 2012 Standard 39服务器：每内核（内核许可） (41)BizTalk Server 2013 Branch 41 BizTalk Server 2013 Enterprise 42 BizTalk Server 2013 Standard 42 SQL Server 2012 Enterprise 42 SQL Server 2012 并行数据仓库43 SQL Server 2012 Standard 43管理服务器（服务器许可 + 管理许可 [服务器或客户端]） (44)Data Protection Manager 2010 for System Center Essentials 45 System Center 2012 R2 Client Management Suite 45 System Center 2012 R2 Configuration Manager 46 System Center 2012 R2 Datacenter 46 System Center 2012 R2 Standard 46 Visual Studio Deployment 2013 Datacenter 46 Visual Studio Deployment 2013 Standard 47专业服务器（服务器许可） (48)Microsoft Dynamics CRM Workgroup Server 2013 48 System Center Virtual Machine Manager 2008 R2 Workgroup Edition49 Windows Server 2012 R2 Essentials 49开发人员工具（用户许可） (51)BizTalk Server 2013 Developer 52 MSDN Operating Systems 52 MSDN 平台52 SQL Server 2012 Developer 52 SQL Server 2012 并行数据仓库开发人员52 Visual Studio Premium 2013 with MSDN 52 Visual Studio Professional 2013 53 Visual Studio Professional 2013 with MSDN 54Visual Studio Test Professional 2013 with MSDN 55 Visual Studio Ultimate 2013 with MSDN 56在线服务（用户或设备订购许可、服务订购许可和/或附加订购许可） (58)组合许可模式 (59)Core Infrastructure Server (CIS) Suite Datacenter 59 Core Infrastructure Server (CIS) Suite Standard 59 Virtual Desktop Infrastructure (VDI) Suite 60附录 1：声明 (62)附录 2：软件保障权益 (65)附录 3：附加软件 (75)产品索引 (80)简介使用本文档这些产品使用权利是 Microsoft 与 Microsoft 批量许可客户之间达成的许可的重要组成部分。

API Q1第九版中文版

质量管理体系纲要用于石油和天然气行业的生产制造组织A P I Q 1 规范2013年6月，第9版生效日期：2014年6月1日质量管理体系纲要用于石油和天然气行业的生产制造组织1范围对于按照石油天然气行业产品规范的制造产品或提供有关制造过程的组织，本规范规定了质量管理体系的最低要求。

本规范规定了组织的质量管理体系要求，来证明其有能力持续提供满足顾客和法律法规要求的可靠的产品和制造有关过程。

如果组织执行本规范规定的活动，可以不对这些活动做删减声明。

由于组织的客观因素，本规范某些要求不能适用时，这些要求可以被删减。

当删减时，应进行删减声明。

此外，删减不能影响组织提供满足顾客和法律法规要求的产品和有关服务的能力或责任。

删减仅限于下列章节：5.4设计和开发5.7.1.2服务5.7.1.5生产和服务过程的确认5.7.5顾客财产5.8试验、测量和监视设备的控制本规范中质量管理体系要求规定的章节要求和文件格式与服务提供和产品相关的服务使用(A P I Q2)一致。

标记“N O T E”的信息不是要求，但提供了理解或阐述了相关要求的指南信息。

2引用标准本规范的应用中下列引用文件是不可缺少的。

引用文件的最新版本(包括修正版)适用为：I S O9000,质量管理体系——基础和术语3术语，定义和缩写3.1术语和定义作为本规范的目的，I S O9000给出的术语和定义以及下列定影应适用。

当I S O9000和本规范的术语定义相同时，应适用下列定义。

3.1.1接收准则a c c e p t a n c e c r i t e r i a对过程或产品性能的可接受性所规定的限制。

3.1.2接收检验a c c e p t a n c e i n s p e c t i o n通过监视和测量验证产品符合规定的要求。

3.1.3校准c a l i b r a t i o n与已知准确度的标准进行的对比与调整。

3.1.4收集c o l l e c t i o n获得、收集和/或系统化满足4.5要求的适用信息的过程。

大众特殊要求

行补偿
12/3/08
履行存档责任（D/TLD 零件）质量审核
产品应国家强制性要求产品或关键特性要求，称为D/TLD零件。过程中相关的关键特性称为D特性（或TLD特性），这些文件/记录在需要时能作
为免责的证据
要求如下： a) 识别存档责任件或存档责任特性 b) 标识：产品开发文件、制造规范、指导文件及记录中标明D或TLD特性 c) B2B ，频次：≥1次/ 年
d) 存档时间：≥15年
e) 对自身供应商链同样实行“履行存档责任管理”要求在审核时没有达到要求，需要列计划进行整改。未达到大众要求时，直接降级到C级并可能冻结业务
12/3/08
解决问题采用升级原则
升级原则
与最高管理层，在集团层面上举行质量会议（Top Q会议）。 Top Q 会议中，有可能将质量绩效降至“C”级。
12/3/08
过程审核
VDA6.3过程审核 a) 审核结果要求为A级 b) 审核结果C级，将冻结业务 c) 审核结果为B级，将在规定期限内整改，以达到自审为A级 d) 产品审核结果有A/B级缺陷时，直接降级为C级
12/3/08
质量能力定级
质量能力总评审由每个产品组的以下各项结果组成 a) 自审：目标为A级。在未在规定时间内达到A级或关键时刻（新车型开发、产品技术更改、重大质量事故）时，大众随时进行过程审核和产品审核。 b) 过程审核与产品审核 c) 供应链的评审，例如对于外包的工序，和 d) 通过具体产品和项目的风险评估所确定的相关项目的质量能力。结果为A/B/C级
b) 由于供应商的供货问题或质量问题而引发计划外的大众汽车集团审核或问题分析。
c) 供应商在自审中自评为 A 级，但在大众汽车集团过程审核中却无法认可 d) 未能在协定时间内达到 A 级，因而需要大众汽车集团进行一次额外的过程审核。 e) 供应商把已指定的或现有的生产范围转移到一个与合同中指定的生产场所不同的场所，因此必须重新进行工厂评审。 f) 进行了重要的过程更改以及在供应链中或已外包的工序中发生了更换，因此需要新的样件检验，和/或质量能力评价。 g) 如果按照 Formel -Q 质量能力要求实施一项行动，例如在 TRL 中确定一个直接保证措施，或TRL 被评价为“红色”，由此产生的差旅费用以及其它相关费用应由供应商进行补偿。按照实际产生的差旅费和人工费用（大众汽车集团审核员在供应商处的人日数）进

21CFR 820 English + Chinese

Subpart A--General Provisions Subpart A——通用要求Sec. 820.1 Scope.(a)Applicability. (1) Current good manufacturing practice (CGMP) requirements are set forth in this quality system regulation. The requirements in this part govern the methods used in, and the facilities and controls used for, the design, manufacture, packaging, labeling, storage, installation, and servicing of all finished devices intended for human use. The requirements in this part are intended to ensure that finished devices will be safe and effective and otherwise in compliance with the Federal Food, Drug, and Cosmetic Act (the act). This part establishes basic requirements applicable to manufacturers of finished medical devices. If a manufacturer engages in only some operations subject to the requirements in this part, and not in others, that manufacturer need only comply with those requirements applicable to the operations in which it is engaged. With respect to class I devices, design controls apply only to those devices listed in 820.30(a)(2). This regulation does not apply to manufacturers of components or parts of finished devices, but such manufacturers are encouraged to use appropriate provisions of this regulation as guidance. Manufacturers of human blood and blood components are not subject to this part, but are subject to part 606 of this chapter. Manufacturers of human cells, tissues, and cellular and tissue-based products (HCT/Ps), as defined in 1271.3(d) of this chapter, that are medical devices (subject to premarket review or notification, or exempt from notification, under an application submitted under the device provisions of the act or under a biological product license application under section 351 of the Public Health Service Act) are subject to this part and are also subject to the donor-eligibility procedures set forth in part 1271 subpart C of this chapter and applicable current good tissue practice procedures in part 1271 subpart D of this chapter. In the event of a conflict between applicable regulations in part 1271 and in other parts of this chapter, the regulation specifically applicable to the device in question shall supersede the more general.(2) The provisions of this part shall be applicable to any finished device as defined in this part, intended for human use, that is manufactured, imported, or offered for import in any State or Territory of the United States, the District of Columbia, or the Commonwealth of Puerto Rico.(3) In this regulation the term "where appropriate" is used several times. When a requirement is qualified by "where appropriate," it is deemed to be "appropriate" unless the manufacturer can Sec.820.1 范围（a）适用性。

国家中心发布药品定期安全性更新报告SUR的常见问题与回答QA

国家中心发布药品定期安全性更新报告PSUR的常见问题与回答Q&A4为更好地规范药品定期安全性更新报告PSUR的撰写和有效控制药品的风险,我中心对生产企业在撰写和报告PSUR中存在的共性问题进行了梳理,并在我中心网站专题专栏的药品定期安全性更新报告常见问题与回答版块发布了药品定期安全性更新报告PSUR常见问题与回答Q&A4;该问答内容包括PSUR覆盖的时间范围、语言要求、安全性信息应包含的内容、我国境内发生药品不良反应/事件报告数据的分析、提交说明书的要求、PSUR递交频率变更的要求等;内容详见链接药品定期安全性更新报告PSUR的常见问题与回答Q&A41.按法规要求每5年提交一次PSUR的产品,是否可以在第5年一次性报告5份1年期的药品定期安全性更新报告PSUR答：不可以;根据药品定期安全性更新报告撰写规范要求,制药企业应以取得药品批准证明文件的日期CBD为起点计,撰写PSUR;如果公司统一的PSUR撰写频率高于我国现行法规要求,依据公司统一的PSUR撰写频率进行提交;可以提交以国际诞生日IBD为起点计的PSUR,且应在第一次提交PSUR时补充IBD和CBD时间间隔内的数据并进行分析,之后保持PSUR数据覆盖时间连续;不接受一次提交多份PSUR的报告方式;如果公司统一的PSUR撰写频率低于我国药品定期安全性更新报告撰写规范,应提交符合我国要求撰写的PSUR;2.进口药品的PSUR,哪些内容需要翻译成中文答：进口药品的定期安全性更新报告中,除病例列表Line Listings和汇总表Summary Tabulations外的其他部分均应翻译成中文,并随翻译后的公司核心数据表Company Core Data Sheet,CCDS和原英文PSUR一起提交;3.进口药品在中国境内发生的安全性信息变更情况是否应纳入PSUR撰写内容中答：应该;按照药品定期安全性更新报告撰写规范要求,进口药品在中国境内发生的安全性信息变更情况应在四药品安全性信息的变更情况部分进行详细介绍;如果公司有全球统一的公司核心数据表如CCDS或RSI文件,请对我国药品说明书与核心数据表中的相应内容进行比较,对于差异部分请解释理由并说明影响；若无统一公司核心数据表,需要与其他国家药品说明书的相应内容进行比较,并解释理由和说明影响;4.进口药品PSUR中是否需要包括中国境内发生的药品不良反应/事件报告数据答：需要;进口药品PSUR中应包含公司在中国境内收到的,以及中国国家药品不良反应监测系统反馈的药品不良反应/事件报告数据;反馈数据的获取应定期与国家药品不良反应监测中心沟通;5. 提交PSUR时对附件中的药品说明书有何要求答：应提交当前最新版本的中文药品说明书;进口药品如无CCDS,还应提交原研国现行的说明书;上报PSUR时,国内药品说明书若已提交修改说明书的补充申请,且尚未得到回复,则应在提交表和正文的“摘要”及“安全性信息变更”中进行说明;6.药品改变包装规格,或增加适应症,是否需要变更PSUR递交频率答：如果药品的监测期未发生变化,当前报告频率不需要调整;监管部门另有要求的,应根据要求调整PSUR递交频率;药品定期安全性更新报告PSUR的常见问题与回答Q&A31. 某进口药品在国外并不按照药品管理,如肠内营养药等,其境外制药厂商是否应当提交PSUR根据药品不良反应报告和监测管理办法卫生部令第81号,该药品的境外制药厂商应当提交PSUR;2. 某进口药品在国外并不按照药品管理,如果该类产品在境外发生与产品有关的不良事件时,是否需要在PSUR中报告需要报告;3. 某进口药品的境外制药厂商在境内没有药品生产企业,在中国境内有办事机构或者由其委托的代理机构,其产品在境内也有总代理商,应当如何提交PSUR该药品的境外制药厂商应当指定其办事机构或代理机构或者境内总代理商作为该药品在境内的安全责任代表,履行报告药品不良反应、提交PSUR等药品安全责任;其办事机构或代理机构或者境内总代理商在获得境外制药厂商的授权后,通过安全责任代表机构所在地的省中心在药品不良反应监测平台注册,然后提交PSUR;4. 该进口药品至今未提交过或者未连续地提交PSUR,应当如何提交PSUR如果该进口药品至今未提交过或者未连续地提交PSUR,企业应当以首次获得进口药品注册证或者医药产品注册证的时间作为首个PSUR报告期的起始时间;药品定期安全性更新报告PSUR的常见问题与回答Q&A21. 某中药在国外以食品补充剂或者食品添加剂非药品身份上市,但是国外有文献报道或者其他途径介绍该产品的安全性信息,该中药的生产企业是否需要在PSUR包含这部分安全性信息需要;2. 某制药企业集团在内部转移产品,比如A企业在2002年首次获得药品批准证明文件该药品无监测期,2004年集团将该产品转移到B企业生产,现在B企业应当如何提交PSURB企业应当以2002年首次获得该药品批准证明文件的时间作为PSUR汇总数据最初的起始时间;3. 如果同一活性成份药品有多个批准证明文件,并且不同批准证明文件相应说明书中有关安全性信息的表述有差异,药品生产企业是否需要将所有说明书都作为附件上传需要;药品定期安全性更新报告PSUR的常见问题与回答Q&A11. 哪些产品不需要提交PSUR对于实施批准文号管理的原料药、辅料、体外诊断试剂,不需要提交PSUR;对于实施批准文号管理的中药材、中药饮片以及进口中药材,不需要提交PSUR;对于境内药品生产企业接受境外委托生产如通过欧盟/FDA等相关国家/地区认证,符合委托国法律法规,但是未获得我国批准证明文件的产品,不需要提交PSUR;2. 对于获得批准证明文件、但长期不生产的药品,是否需要提交PSUR需要提交;3. 仿制药是否需要提交PSUR需要提交;4. 非处方药是否需要提交PSUR需要提交;5. 对于之前并未提交定期汇总报告或者PSUR的国产药品,应当如何确定首个PSUR报告期的起始时间按照PSUR报告期应当连续完整、不应当有遗漏或者重复的原则,对于之前并未提交定期汇总报告或者PSUR的国产药品,药品生产企业应当以首次获得国家局批准证明文件的时间作为首个PSUR报告期的起始时间;6. 对于设立新药监测期的国产药品,应当如何提交PSUR根据药品不良反应报告和监测管理办法卫生部令第81号第三十七条第一款规定,设立新药监测期的国产药品,应当自取得批准证明文件之日起每满1年提交一次定期安全性更新报告,直至首次再注册,首次再注册完成之后每5年报告一次;7. 对于原地标升国标药品,应当如何提交PSUR药品生产企业应当以国家食品药品监督管理局统一换发药品批准文号的时间作为PSUR汇总数据最初的起始时间;根据药品不良反应报告和监测管理办法卫生部令第81号第三十七条第一款规定,原地标升国标药品不属于设立新药监测期的国产药品,应当每5年报告一次PSUR;例如,某原地标升国标药品于2002年12月31日获得批准证明文件,对于这个药品,首次提交PSUR的数据截止日应为2012年12月30日;该药的报告期可能存在两种情况：①企业如果已经系统、连续地提交过定期汇总报告,那么这次的报告期是自上次定期汇总报告数据截止日之后一日开始,至2012年12月30日;②如果企业并未系统、连续地提交过定期汇总报告,那么这次的报告期就是2002年12月31日—2012年12月30日;8. 如果同一活性成份药品有多个批准证明文件,药品生产企业该如何提交PSUR根据药品不良反应报告和监测管理办法卫生部令第81号和关于印发定期安全性更新报告撰写规范的通知国食药监安2012264号,对于同一活性成份药品有多个批准证明文件涵盖不同给药途径、适应症功能主治或目标用药人群等,药品生产企业可以按照一个批准证明文件提交一份PSUR；也可以遵循化学药和生物制品按照相同活性成分、中成药按照相同处方组成在一份PSUR中进行报告,以多个批准证明文件中最早的批准时间作为汇总数据最初的起始时间、按照最严格的时限要求报告,但需要根据药物的不同给药途径、适应症功能主治或目标用药人群等因素进行分层;例如,有药品生产企业在2011年1月25日获得一个片剂的批准证明文件,该药有监测期；在2014年9月7日又获得相同活性成分注射剂的批准证明文件,该药也有监测期,该企业在提交PSUR时有2种选择：①根据批准证明文件分别提交;对于这个例子中的片剂,药品生产企业应当以2012年1月24日为数据截止日提交PSUR,以后每年提交一次PSUR,直至首次再注册；之后每5年报告一次;对于这个例子中的注射剂,药品生产企业应当以2015年9月6日为数据截止日提交PSUR,以后每年提交一次PSUR,直至首次再注册；之后每5年报告一次;②根据同一活性成分提交一份PSUR;对于这个例子中的片剂,药品生产企业应当以2012年1月24日、2013年1月24日、2014年1月24日为数据截止日提交PSUR;由于2014年9月7日获得批准证明文件的注射剂同样有监测期,对于该活性成分药品,药品生产企业应当以2015年1月24日为数据截止日提交PSUR,以后每年提交一次PSUR,直至该注射剂首次再注册；之后每5年报告一次;9. 对于未按时提交PSUR的,是否国家药品不良反应监测系统不再接收该产品的PSUR不会;药品生产企业仍可以向国家药品不良反应监测系统报送,系统不会拒绝接收;但需要强调的是,系统能够接收PSUR并不意味着药品生产企业已按照要求提交PSUR;10. 有国内药品经营企业作为进口药品在国内的总代理,但是药品经营企业并没有权限提交PSUR,应该怎么解决目前系统并未默认药品经营企业有权限提交PSUR;但药品经营企业作为进口药品在国内的总代理,有责任和义务提交PSUR;在省中心给辖区内的药品经营企业分配PSUR权限之后,药品经营企业即可通过药品不良反应监测平台上报PSUR;省中心可以在“集成”的“用户管理”或“机构管理”中完成权限分配;。

1、下载文档前请自行甄别文档内容的完整性，平台不提供额外的编辑、内容补充、找答案等附加服务。
2、"仅部分预览"的文档,不可在线预览部分如存在完整性等问题,可反馈申请退款(可完整预览的文档不适用该条件!)。
3、如文档侵犯您的权益，请联系客服反馈,我们会尽快为您处理(人工客服工作时间：9:00-18:30)。

技术参考-F&Q SY(2012/04第17周)现象1：A55主板下使用MHDD识别不到硬盘。

原因：MHDD不支持SATA硬盘运行在原生IDE模式。

解决方法：Advanced→SATAconfiguration→onchip SATAtype【Native IDE】改为【Legacy IDE】
现象2：无盘环境下，提示tftp open timeout1，无法进入系统。

原因：服务器的IP地址和在控制台上面分配给客户机用的IP地址不是同一个网段的，或交换机屏蔽了TFTP或者有客户机连到了交换机上的级联端口。

解决方法：检查服务器控制台IP设置，交换机接口，69端口是否开启。

现象3：P6HK V21在网吧万象登录界面出现随机死机。

原因：使用盗版万象程序、程序版本低。

无盘系统工包驱动不兼容。

解决方法：更新万象程序至最新版本。

开启超管，正确识别驱动后，保存设置。

现象4：用户咨询，为什么4G内存XP32位系统显示2.75G，而识别不到3.25。

原因：32位系统所提供的内存地址分配机制最高支持到4G，而WINOWS的内存I/O映射会把内存地址分配与主板寄存器、PCI总线、显卡总线等。

所以不同的平台下，内存地址的分配占用会有所差异。

对实际性能并无影响。

解决方法：安装64位操作系统，即可识别4G及以上内存容量。

现象5：990FX X7V14鲁大师、360提示报警，主板温度9090°°C以上。

原因：软件读取I/O寄存器数值偏差，对I/O芯片针脚定义不能正确识别，或芯片温度为虚值。

解决方法：建议卸载鲁大师，使用AIDA64进行稳定性测试。

另附，APU混合交火几点事项：
*1.操作系统必须为WINDOWS7，ATI催化剂版本使用最新版。

驱动控制台内性能选项中勾选CROSSFIRE
2.主输出显卡端，要与BIOS内设置对应ADVANCED→GRAPHICS CONFIGURATION→PRIMARY VIDEO DEVICE
3.开启交火选项，ADVANCED→GRAPHICS CONFIGURATION→CROSSFIRE
4.对应显卡显存的容量适当调节APU的共享显存与之均衡，ADVANCED→GRAPHICS CONFIGURATION→UMA
5.APU与独显搭配，型号上有硬性规定，附表参考：
技术参考-F&Q SY(2012/05第19周)现象6：TWINS型号主板当DDR2BIOS坏时，用DDR3如何引亮？
答：关机情况下，拆掉DDR2和DDR3BIOS块，把DDR3BIOS块按置于DDR2BIOS块位置。

用AM3+DDR3启动，进入BIOS界面，关闭主板写保护后，进入DOS下刷新BIOS界面后，拆除DDR3BIOS块，将好事先拆掉的DDR2BIOS块重新按置于DDR2BIOS块位置，执行刷新。

刷新后DDR2和DDR3BIOS块重新按置默认位即可。

DDR3不亮时，同理操作。

（早期AM2+的TWINS型号主板是双BIOS块设计。

）
现象7：问题二：主板详细参数，支持功率大小？
答：登录，选择进入产品目录，如图：
进入后，选择芯片厂家及具体型号，如图：
进入后，选择“规格”，将予显示具体参数规格，如图：
现象8：NVIDIA520型号显卡“粉屏”？
答：使用NVIDIA最新WHQL认证296.10版驱动，未发现此问题复现。

怀疑驱动不兼容造成，建议安装GHOST系统过程中，不要释放GHOST自带显卡驱动。

现象9：分享一下我们目前能上推士机的主板？
答：AMD官方发布只有AM3+接口的990、970芯片主板支持新一代“推土机”CPU。

如我司战旗C.A990FX X7V14和战斧C.A970X5V14两款型号。

厂商通过对AM3+接口针脚定义的破解以及BIOS的升级亦可支持，如我司战斧 C.A870V15（I/O芯片带有PLUS+字样）。

现象10：网吧使用显卡长时间运行温度高。

答：如使用四针温控风扇显卡，运行Furmark负载测试，观察风扇转速是否异常。

确认问题后，提供具体型号，原卡BIOS文件，与沈阳售后部对接。

也可以使用NVIDIA SYSTEM TOOL 进行调节，如图：
现象11：整机时亮，时不亮。

答：在系统C:\Documents and Settings\Administrator\「开始」菜单\程序\启动位置导入shutdown-r-t30BAT文件。

将自动执行开机30s后重启动作。

无需长时间看守，待问题复现后，观察DEBUG卡代码。

排查问题点。

现象12:INTEL H6X芯片主板，接USB键鼠后进系统，滚动条周期长的情况
答：INTEL官方发布9.2.3.1022版驱动修正PCI、USB设备工作不正常的情况。

经过验证，更新驱动后，进系统滚动条周期正常，一般3~5圈即可进入系统。

解压释放文件后，直接执行安装SETUP.EXE进行安装。

或在“设备管理器”中的“通用串行总线控制器”中，找到“INTEL 6series XXX.....”字样的设备，右键更新X:\INF_allOS_9.2.3.1022_PV\All目录中的INF 文件。

技术参考-F&Q SY(2012/05第21周)现象13：A55为什么不支持待机状态？图标是灰色的。

答：CMD下执行powercfg-a命令行,显示不支持S1/S2/S3待机模式。

AMD HUDSON D1/D2/D3系列芯片组型号：A75、A55、AE50等主板型号，受芯片功能限制，硬件不支持S1待机功能。

现象14：DDR31600MHz内存，只显示1333MHz频率。

答：首先CPU和主板规格上要支持。

再是，有些标注1600MHz的内存，其实是可OC 1600MHz，实际上是1333MHz的规格。

CPU:AMD官网提供的资料显示，只有“推土机FX”系列和“APU”系列CPU支持1600MHz、1866MHz频率。

INTEL官网资料显示，22NM酷睿三代支持1600MHz。

主板：一般都是对应芯片官方规格和CPU规格去设定。

少数型号支持OC1600MHz，需超频，与CPU外频、主板FSB以及内存电压有关。

另，从P55芯片开始，INTEL XMP 技术可实现，但需要内存支持XMP技术。

BIOS设置：以战斧C.A970X5V14为例。

Colorful Magic Control-DRAM Timing Configuration-Memory Clock Speed设置800MHz。

Colorful Magic Control-DIMM Voltage适当调节内存电压，一般在1.65V左右。

还可通过CPU-Z显示提供的内存SPD信息，详细设定内存800MHz频率下运行的子参。

多条内存时，非套装内存，SPD可能差异存，在子参设定的时候，范围适当加宽。

网络上有很多这样的疑问。

现象15：网吧使用A87K V18主板搭配AMD640CPU，出现个别机器游戏卡顿、无法运行等异常情况。

答：实际观察系统下的CPU状态，CPU核心显示为六核。

怀疑CPU为GR后缀批次的“被屏蔽核心的羿龙”，实际是“640T”。

六核CPU会在无盘系统下导致游戏异常的情况，尤其是存在不良核心的“开核CPU”。

BIOS下恢复安全值设置即可。

或刷新关闭开核功能BIOS。

下载地址：/file/c22a6ecc。